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P A R T I 
I N T R O D U C T I O N 
I. INTRODUCTION 
The syndrome of Malignant Hyperpyrexia 
in man follows administration of certain 
general anaesthetic agents, and, although 
rare, is fatal in 70% of cases (EDITORIAL, 
1968). Following exposure to the anaes-
thetic, there is, in most instances of 
susceptible individuals, a rapid rise in 
body temperature, usually within a period 
of 10 minutes, often accompanied by muscu-
lar rigidity of the limbs~ Sometimes 
hyperthermia has.been delayed for hours 
and muscular rigidity not pronounced. The 
temperature reached maybe 43°C (115°F) or 
even somewhat above this. Halothane, 
CF3CHBrCl, a ha../o/~nated
 hydrocarbon, is 
thought to be responsible for most cases 
(WILSON, NICHOLS, DENT and ALLEN, 1966). 
Succinyl choline lfH2COOCH2CH2*(cH3 )~ 201
_ 
~H2COOCH2CH2~(cH3 )3 
a skeletal muscle relaxant employed during 
anaesthesia, has also been implicated (BRITT 
and KALOW, 1970; HARRISON, 1971). 
A similar syndrome has been described 
in· a certain strain of Landrace pig (HARRI-
SON, BIEBUYCK, TERBLANCHE, DENT, HICKMAN and 
SAUNDERS, 1968). Malignant Hyperpyrexia in 
pigs, when induced by halothane or succinyl 
choline, is indistinguishable from the human 
conditions and is accompanied by 
(1) increase in body temperature to 42-45°C 
(2) a severe systemic lactacidosis 
(3) stiffness or rigor of skeletal muscle and 
(4) changes in the water and electrolyte meta-
bolism (BERMAN, HARRISON, BULL and KENCH, 1970). 
The present study was undertaken to dis-
cover whether the severe lactacidosis found 
in these animals was due to activation of the 
rate-limiting enzymes in the glycolytic path-
way in skeletal muscle of affected animals, 
and also to investigate the possible mechanism 
by which halothane or succinyl choline might 
stimulate enzymes or provoke the syndrome of 
hyperthermia. More specifically, our inten-
tion was to identify the step or steps of the 
glycolytic pathway which become activated and 
result in massive release of lactic acid in 
-2-
skeletal muscle. Possible mechanisms by 
which halothane or succinyl choline could 
stimulate the enzymes concerned would be 
explored. Previous studies have not im-
plicated anoxia as a factor stimulating 
glycolysis in this condition (BERT1AN, HAR-
RISON, BULL and KENCH, 1970). 
II. THE CONTROL OF GLYCOGEN METABOLISM 
IN MUSCLE. 
A. THE EMBDEN-MEYERHOF PATHWAY 
This pathway may be considered to com-
prise those steps by which carbohydrate sub-
strates are metabolised anaerobically to 
pyruvate (Fig. 1 and 2). The initial sub-
strate, either glycogen or glucose, enters 
the pathway by phosphorylation, either by 
inorganic phosphate (phosphorolysis of glyco-
gen) or by ATP (hexokinase reaction for glucose). 
An additional phosphorylation is involved with 
the consumption of ATP during the conversion 










k~~~;:HATASE i PHOSPHOGLUCOMUTASE 
GLUCOSE li.> GLUCOSE-6-PHOSPHA TE 
ATP ~ADP * PHOSPHOGLUCOSE ISOMERASE 
FRUCTOSE-6-PHOSPHA TE 
FRUCTOSE-1,6-DIPHOSPHATASE ·i ATP:.' . PHOSPHOFRUCTOKI NASE 
ADP~ 
FRUCTOSE-1,6-DIPHOSPHATE t ALDOLASE 
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GL YCERALDEHYDE- 4 1RIOSE PHO SP HA TE . . DIHYDROXYACETONE 
3-PHOSPHATE ""41 I SOMERASE ~ PHO SP HA TE 
NAD+l.;_ l', GLYCERALDEHYDE-3- NADH~.'. . GLYCEROL-PHOSPHATE 
, .. PHOSPHATE DEHYDROGENASE ~ DEHYDROGENASE 
NADH NAD+ . 
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ADP · 
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3-PHOSPHOG L YCERATE 
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+H20 !' ENO LASE, Mg +1-
-H 0 . ' 2 
PHOSPHOENOL PYRUVATE 
ADP. · ·j lPXRUVW KINASE 
K ' /Vig 
ATP . " IAC TIC DE HYDR OGE NASE 
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FIG. 2 
CONTROL OF GLYCOL YSIS 
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di:pho s:phat e. Each of these :phosphorylation 
steps appears to function as a control point 
for the regulation of the rates of glycolysis 
and glycogenolysis. The rate of flux along 
the :pathway will be influenced by the availa-
bility of certain cofactors. Thus, lack of 
ADP will inhibit the :pyruvate kinase reaction 
and, similarly, insufficient NAD+ will impede 
the conversion of glyceraldehyde-3-:phos:phate 
to 3-:phos:phoglycerate, as catalysed by 
glyceraldehyde-3-:phos:phate dehydrogenase. 
The regeneration of NAD+ by the conversion of~ 
:pyruvate to lactate 
~ LACTIC DEHYDROGENASE 
CH3-C-COOH ------,I}> C> CH3-CHOH-COOH 
NADH : H+ NAD+ 
PYRUVATE LACTATE 
allows glycolysis to continue under anaerobic 
conditions, and is the reason for lactate ac-
cumulation during rapid glycolysis. Two 
other systems could be affected by NADH accu-
mulation, namely: 
-6-

























In the following discussion, steps known 
to be control points of glycogenolysis will 
be considered in most .detail. When Mal ig-
nant Hyperpyrexia was induced in whole living 
animals, with the development of lactacidosis 
blood glucose concentration did not fall, but 
rose significantly. It was inferred that 
glycogen was probably the sole source of lac-
tate. The hexokinase reaction will not, 
therefore, be further considered. 
B. GLYCOGE~ SYNTHESIS IN MUSCLE 
Synthesis of glycogen in vitro by a 
purified enzyme was achieved by CORI, SCHMIDT 
and CORI, 1939. It was generally accepted 
for a long time that phosphorylase in vivo 
w~sresponsible for the synthesis, as well 
as for the breakdown of glycogen, in view 
of the fact that the phosphorylase reaction 





+ INORGANIC PHOSPHATE 
(CORI, CORI and GREEN, 1943). 
However, demonstration of the absence of 
phosphorylase in glycogen storage disease of 
muscle in man, McArdle's Syndrome (McARDLE, 
1951) was a strong indication that glycogen 
synthesis and catabolism are independent pro-
cesses. This is now clearly established, in 
addition to the reciprocal actions of inhibi-
tors and stimulators of these independent 
pathways. 
-8-
The discovery of an enzyme in liver, 
uridine diphosphate glucose-glycogen-
transglucosylase (glycogen synthetase), 
which is responsible for the transfer of 
glucose from uridine diphosphate glucose 
(UDPG) to glycogen proved that phosphory-
lase plays no significant role in glycogen 
synthesis (LELOIR and CARDINI, 1957). 
fro,n 9/u.c0s0 
Synthesis of glycogenAis ~resently 
envisaged as follows: 
1. 
HEXOKINASE 




2. GLUCOSE-6-PHOSPHATE ~---------~~~---~ 
GLUCOSE-1-PHOSPHATE 
3. URIDINE TRIPHOSPHATE + GLUCOSE-1-PHOSPHATE 
UDPG 
--~~~~~~~-,£> UDPG + PYROPHOSPHATE 
PYROPHOSPHORYLASE 
4. URIDINE DIPHOSPHATE GLUCOSE + PRIMER 
GLYCOGEN 
----~ GLYCOGEN + URIDINE DIPHOSPHATE 
SYNTHETASE 
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(i) Properties of Glycogen Synthetase 
Glycogen synthetase in muscle exists in 
two interconvertible forms, one of which is 
dependent on glucose-6-phosphate for activity. 
This form has been called the dependent or D 
form. The other form is active in the absence 
of glucose-6-phosphate and has been called the 
independent or I form. 
The I and D ·forms have been found in skele-
tal muscle of rat (ROSELL-PEREZ, VILLAR-PALASI 
and LARNER, '1962), lamb (TRAUT and LIPMAN, '1963), 
rabbit and dog (ROSELL-PEREZ and LARNER, '1964 
(a) and (b)), in the fatbody of the silkmoth 
(MURPHY and WYATT, '1995), mature human erythro-
cytes and leucocytes (CORNBLATH, STEINER, BRYAN 
and KING, '1965) and in normal human lymphocytes 
(HEDESKOV, ESl'1ANN and ROSELL-PEREZ, '1966). 
Conversion of the I to the D form requires 
ATP and Mg++. The change is catalyzed by 
transferase I kinase and involves the transfer 
of the terminal phosphate from ATP to the enzyme 
in which a serine residue is phosphorylated. 
The reverse conversion of the D to the I form 
is catalyzed by transferase D phosphatase, and 
-'10-
is accompanied by loss of inorganic phosphate 
from the enzyme. 
('1) GLYCOGEN SYNTHETASE I + r'l..ATP 
TRANSFERASE I 
. KINASE -------6> 
Mg++ 
GLYCOGEN SYNTHETASE D + nADP 
(2) 
TRANSFERASE D 
GLYCOGEN SYNTHETASE D ~P_H_O_S_P_H_A_T_A_S_E---;t') . 
-'1 '1-
GLYCOGEN SYNTHETASE I+ nINORGANIC 
PHOSPHATE 
(FRIEDMAN and LARNER, '1963). 
Purified rabbit skeletal muscle phosphory-
lase b kinase and activated phosphorylase b 
kinase,produced by incubation with cyclic AMP 
and ATP, had no significant effect upon glyco-
gen synthetase I as substrate. Therefore the 
kinase responsible for the phosphorylation of 
glycogen synthetase I and phosphorylase bare 
different enzymes (FRIEDMAN and LARNER, '1965) 
The action of ca++ ions on the conversion 
of glycogen synthetase I to D form in rat skele-
tal muscle has also been investigated. Ca++ 
promotes the I to D conversion in muscle. 
This change does not involve ATP, and is not 
affected by cyclic .AI'1P. It requires, however, 
a protein factor which is very similar to that 
involved in the activation of inactive phospho-
rylase b kinase by Ca++ (BELOCOPITOW, APPLEMAN 
and TORRES, 1965). 
The properties of glycogen synthetase D, 
as prepared by incubation with Ca++ or with 
ATP have been compared. The two preparations 
exhibited different sensitivity to the action 
of heat and trypsin. Glycogen synthetase D 
f d . th f C ++ . . orme in e presence o a is more sensi-
tive to heat treatment and less stable on 
storage at ~20°c than glycogen synthetase D 
generated with ATP. The glycogen synthetase 
D obtained with ATP is reconvertible to the I 
form, while that prepared with Ca++ is not 
(BELOCOPITOW, FERNANDEZ, BIRNBAUI1ER and TORRES, 
1967). These observations suggest that ca++ 
may not be the physiological inactivator of 
this system. 
ATP and ADP are potent inhibitors for 
both forms of the enzyme isolated from rat 
skeletal muscle but .AI'1P and inorganic phosphate 
cause much less inhibition. Addition of 
glucose-6-phosphate reverses this inhibition 
of ATP, ADP, AMP and inorganic phosphate to 
a great extent. However, the inhibition 
caused by UDPG, a substrate analogue, is not 
relieved by the addition of glucose-6-phosphate 
(PIRAS, ROTH1'1AN and CABIB, 1967). 
The effect of glycogen on the transferase 
D phosphatase activity in isolated perfused 
rat heart has also been studied. Transferase 
D phosphatase, which abets the conversion of 
the D to I form, was shown to be inhibited by 
glycogen in vitro (HUIJING, NUTTALL, VILLAR-
PALASI and LARNER, 1969). 
The relative distribution of glycogen 
synthetase as I or Din mouse skeletal muscle 
and in isolated intact rat diaphragm is re-
lated to the tissue concentration of glycogen. 
Glycogen synthesis is thus regulated by an un-
known mechanism which influences the intercon-
version of glycogen synthetase I to Din such 
a way that it favours glycogen synthesis when 
the tissue concentration of the polysaccharide 
is low, and decreases glycogen synthesis when 
its.~ concentration is high. 
Presumably, inhibition of transferase D 
phosphatase by glycogen arises as a conse-
quence of an allosteric conformational change 
in the active site of the enzyme, induced 
through interaction of the polysaccharide 
with a region of the enzyme molecule in the 
neighbourhood of the active site. Activation 
of glycogen synthetase D by glucose-6-phosphate 
could be the manifestation of an allosteric 
modification of the tertiary structure of the 
enzyme. 
Insulin stimulates glycogen synthesis in 
isolated rat diaphragm (DANFORTH, ~965). 
The in vivo effect of insulin on muscle glyco-
gen synthetase activity of rat muscle has been 
investigated (VILLAR-PALASI and WENGER, 1967). 
Five minutes after the injection of rats with 
insulin, glycogen synthetase I activity had 
increased by 60% and after 10 minutes had risen 
by 90%. There was, however, no change in the 
total glycogen synthetase activity (that is, I 
and D combined) or in the glycogen content of 
the muscle. Insulin had no influence on trans-
ferase D phosphatase activity which converts 
the D to I form, but caused a marked decline 
in transferase I kinase activity which cata-
lyzes the I to D conversion. The fall in 
transferase I kinase activity of rat muscle 
extracts following administration of insulin 
was rectified by the addition of cyclic AMP. 
It is assumed, therefore, that there 
are two glycogen synthetase kinases, one de-
pendent on cyclic AMP for activity, and th~ 
other independent of cyclic AMP, both cata-
lyzing the conversion of the I to D form. 
C. GLYCOGEN DEGRADATION 
The complet~ degradation of glycogen in 
animal tissues requires two enzymes: 
(a) Phosphorylase, for the phosphorolysis, 
through the action of inorganic orthophosphate, 
on the o<:-1:4-linkages between glucose residues 
of unbranched portions of the glycogen molecule. 
Glucose residues are removed singly and progres-
sively from the outer exposed ends of glycogen 
until a 1:4 - 1:6 branch is reached. From each 
-15-
glucose residue thus "whittled away" one 
molecule of glucose-'1-phosphate is formed. 
(b) Amylo-'1,4 - '1,6 transglucosidase, also 
called the debranching enzyme, which facili-
tates hydrolysis of the '1,6 glucosidic link-
age at each branch point, with the production 
of one molecule of free glucose (CORI and 
LARNER, '195'1. 
(i) Skeletal Muscle Phosphorylase 
Phosphorylase exists in skeletal muscle 
in two forms that have been designated phos-
phorylase ~ and phosphorylase b. 
Phosphorylase a, also known as the active 
form, possesses 60 - 70% of its maximal activi-
ty in the absence of AMP. Phosphorylase b, 
known also as the inactive form, has an absolute 
requirement for AMP. In the presence of AMP 
both phosphorylase a and b have the same acti-
vity per mg. of protein (CORI and GREEN, '1943). 
Isolation and crystallization of rabbit 
skeletal muscle phosphorylase was achieved by 
GREEN and CORI, '1943. Resting rabbit skeletal 
muscle contains phosphorylase predominantly in 
-'16-
the b form (KREBS and FISCHER, 1955). 
Phosphorylases have been isolated and crys-
tallized from a number of tissues; phospho-
rylase b from rabbit skeletal muscle (FISCHER 
and KREBS, 1958), both a and b forms from 
human autopsy skeletal muscle (YUNIS, FISCHER 
and KREBS, 1960), frog skeletal muscle (METZGER, 
GLASER and HELl'1REICH, 1968), human blood plate-
lets (KARPATKIN and LANGER, 1969), liver 
(SUTHERLAND and WOSILAIT, 1956), rat and beef 
kidneys (VILLAR-PALASI and GAZQUEZ-MARTINEZ, 
1968) and from lobster muscle (COWGILL, 1959). 
The earlier determinations of the size of 
crystalline rabbit muscle phosphorylase revealed 
a molecule with a molecular weight between 
340 000 and 400 000 daltons (ONCLEY, 1943). 
It was established later that rabbit skeletal 
muscle phosphorylase a and b have a molecular 
weight of 495 000 and 242 000 daltons respect-
ively, i.e. phosphorylase b has half the mole-
cular weight of phosphorylase ~ (KELLER and 
CORI, 1953). A reinvestigation into the 
molecular weight of phosphorylase a and b has 
given values of 370 000 and 185 000 respectively 
(SEERY, FISCHER and TELLER, 1967). 
Phosphorylase a and b can also be further 
dissociated into subunits or monomers by treat-
ment with certain mercurial compounds, such as 
parachloromercuribenzoate (p-CMB). Each sub-
unit has a molecular weight of 92 000, which 
is in agreement with the more.recent determina-
tions of native a and b forms. Phosphorylase 
a, which is a tetramer, gives four phosphorylated 
subunits of equal molecular weight and phospho-
rylase b, which is a dimer, produces two non-
phosphorylated subunits of equal molecular 
weights when treated with p-CMB (MADSEN and 
CORI, 1956) (Fig. 3) 
The determination of the amino acid compo-
sition of rabbit muscle phosphorylase, using 
microbiological, isotopic and spectrophotometric 
techniques, was achieved by VELICK and WICKS, 
(1951). The amino acid compositions of frog, 
rabbit and human skeletal muscle phosphorylases 
are quite similar, but the frog and rabbit skele-
tal muscle phosphorylases differ immunologically 
(METZGER, GLASER and HELMREICH, 1968). 
The presence of a vitamin B6 
derivative as 
a component of phosphorylase was first reported 
by VELICK and WICKS (1951). Phosphorylase a 
-18-
. · FIG. 3. 
AGGREGATION-DISSOCIATION OF GLYCOGEN PHOSPHORYLASE SUBUNITS 
PHOSPHORYLASE b 
185 000 d 
p-CMB. 
rvvo MONOMERS 
92 000 d 
PHOSPHATASE 
KINASE 
( Fl SCHER AND KREBS, 1966) 
PHOSPHORYLASE a 
370 000 d 
p-CMB 
FOUR MONOMERS 
92 000 d 
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contains eight organic phosphate groups 
per mole or two phosphate groups per sub-
unit with a molecular weight of 125 000 
daltons. Four of these phosphate groups 
could be extracted by precipitation of the 
enzyme with trichloracetic acid (TCA) or 
perchloric acid (PCA). The TCA or PCA-
soluble compound was isolated and identified 
as pyridoxal-5'-phosphate (BARANOWSKI, 
ILLINGWORTH, BROWN and CORI, 1957). Rabbit 
muscle phosphorylase a and b contain four 
and two moles respectively of firmly bound 
pyridoxal-5'-phosphate per mole of enzyme 
and the enzyme is inactive after the removal 
of pyridoxal-5'-phosphate. On incubation 
of the enzyme with quantities of pyridoxal-
5'-phosphate slightly greater than those 
removed from the enzyme, reactivation occurs. 
Pyridoxamine-5'-phosphate and free pyridoxal 
cannot replace pyridoxal-5'-phosphate (CORI 
and ILLINGWORTH, 1957). Pyridoxal-5'-phosphate 
has also been reported to be present in phos-
phorylase of cat muscle (KENT, KREBS and 
FISCHER, 1958), of frog skeletal muscle 
(METZGER, GLASER and HELMREICH, 1968) and 
likewise in the enzyme of human muscl,e (YUNIS, 
-20-
FISCHER and KREBS, 1960). 
The function of bound B6 cann
ot as yet 
be explained although it is obviously neces-. 
sary for enzyme activity. No mechanism 
comparable to its decarboxylating function 
in the pyruvate or o(-oxoglutarate dehydro-
genase systems or its role in transamination 
can be imagined. Perhaps its salient impor-
tance relates to stabilization of the quater-
nary structure of the enzyme, as a tetramer 
requisite for its catalytic activity. 
Phosphorylase a and b bind four and two 
moles of AJVIP per mole of protein respectively. 
Phosphorylase a has four binding sites for 
this nucleotide, one on each subunit, with a 
molar dissocation constant of the complex of 
1.5 x 10-6 • Phosphorylase b has two binding 
sites for AJVIP, one on each subunit, with a 
molar dissociation constant of 50 x 10-
6 
MADSEN and CORI, 1957). The lower affinity 
of the b form for AJVIP, an essential cofactor 
for activity, is relevant to control of phos-
phorylase activity in vivo. 
It is now well established that phospho-
rylase is an "SH-enzyme", i.e. an enzyme whose 
-21-
activity is dependent on the presence of 
one or more thiol (-SH) groups. Reagents 
which react with the thiol functions 
para-chloromercuribenzoate (MADSEN and 
CORI, 1956; MADSEN and GURD, 1956; KUDO 
and SHUKUYA, 1964), N-ethylmaleimide (KUDO 
and SHUKUYA, 1964), iodoacetoamide (BATTELL, 
ZARKADAS, SMILLIE and MADSEN, 1968), 2,4-
dinitro-1-fluorob'enzene(PHILIP and GRAVES, 
1968) and 5,5'-dithiobis(2-nitrobenzoic 
acid) (KLEPPE and DAMJANOVICH, 1969) can in-
hibit activity completely. The -SH groups 
do not appear to participate in the aggre-
gation-dissociation phenomena. 
The activation of phosphorylase b by 




dine (H2N-(CH2 )4-NH-(CH2 )3
-NH2 ) and putrescine 
(H2N-(CH2 ) 5
-NH2 ). Spermine and §permidine 
have been found in relative abundance in 
preparations of pH 5 enzymes from rat brain, 
and may play a role in microsomal protein 
synthesis (GIORGI, 1970). Stimulation of 
phosphorylase b by polyamines is more pro-
nounced at low AMP concentrations. When 
-22-
phosphorylase a is incubated with trypsin, 
it is converted into yet another active 
phosphorylase, phosphorylase b'. 
TRYPSIN 
PHOSPHORYLASE a C) PHOSPHORYLASE b' 
Phosphorylases a and b' are.not significantly - -
activated by spermine at either high or low 
.AI'1P concentrations, nor is phosphorylase a 
activated significantly by spermine in the 
absence of .AI'1P. Spermine was found to be 
the most effective of the polyamines in the 
activation of phosphorylas.e b, whilst putres-
cine was the least effective (WANG, HUJ:INISKI 
and BLACK, 1968). 
Crystalline rabbit muscle phosphorylase 
~' in the absence as well as in the presence 
of .AI'1P, is inhibited by very small amounts 
C,ugm) of salmine, but, paradoxically, the 
extent of inhibition falls as the salmine 
concentration is increased. 
The affinity of phosphorylase b for .AI'1P 
and IMP is greatly augmented in the presence 
of salmine. Salmine, however, has no effect 
-23-
on the activity of phosphorylase b', produced 
by the action of trypsin (KREBS, 1954). The 
exact significance of the effects of polyamines 
remains obscure. 
Inhibition of phosphorylase b by glucose-
6-phosphate is partially competitive with 
respect to AMP, an activator (WANG, TU and LO, 
1970). Interaction between the activator and 
inhibitor of phosphorylase bis allosteric in 
nature, a negative heterotropic interaction. 
A negative heterotropic interaction is one in 
which conformational changes are induced, by 
the inhibitor, at the binding site in the 
enzyme for substrate or activator. In the. 
presence of 20ml'1 glucose-6-phosphate, the 
affinity of the enzyme for the activator AMP 
was lowered 10-18 fold. 
(ii) The conversion of phosphorylase b to 
phosphorylase ~-
The conv~rsion of phosphorylase b to 
phosphorylase a is depicted in Fig. 4. 
-24-
FIG. 4 
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The change of rabbit skeletal muscle 
phosphorylase b to,a, catalyzed by an enzyme 
which requires ATP and Mg++ has been studied 
by FISCHER and KREBS (1955). Experiments 
with a _3 2P-labelled ATP revealed that phos-
phate was transferred from the terminal 
phosphate of ATP to phosphorylase a (KREBS 
and FISCHER, 1956). It was established 
that four moles of phosphate are incorporated 
per mole of phosphorylase a and four moles of 
ADP are formed. 
PHOSPHORYLASE 
2 PHOSPHORYLASE b + 4ATP C> 
b KINASE 
PHOSPHORYLASE a + 4ADP 
Krebs and Fischer proposed that the 
enzyme catalyzing this reaction be called 
phosphorylase b kinase, since it involved 
the transfer of the terminal phosphate of 
ATP. This reaction was later shown to be 
irreversible (KREBS, KENT and FISCHER, 1958). 
A serine residue in phosphorylase bis the 
acceptor of phosphate, and the primary amino 
-26-
acid sequence in the site has the following 
structure; LYS-GLU.NH2-ILEU-SER.P-VAL-ARG 
(FISCHER, GRAVES, CRITTENDEN and KREBS, 1959). 
Rabbit skeletal muscle phosphorylase b kinase 
has been prepared as a nearly homogeneous pro-
tein (DE LANGE, KEMP, RILEY, COOPER and KREBS, 
1968). 
When extracted ,from rabbit skeletal 
muscle, part of the phosphorylase b kinase so 
obtained is inactive when assayed at pH 6,8 
or below and is referred to as the non-active 
phosphorylase b kinase. Above this pH, the 
enzyme is active, reaching a maximum at pH 
8,2, and is called active phosphorylase b 
kinase. The ratio of activity at pH 6,8 
and pH 8,2 is employed as an index of the 
relative activity of the kinase (KREBS, GRAVES.· 
and FISCHER, 1959). A rise in the pH 6,8 to 
8,2 ratio was demonstrated in isolated muscle 
enzyme systems (POSNER, HAI"IT1ERT1EISTER, BRATVOLD 
and KREBS, 1964) and also after the adminis-
tration of epinephrine to frog and rat muscle 
(POSNER, STERN and KREBS, 1965; DRUT1!'10ND, 
HARWOOD and POWELL, 1969), in perfused rat 
hearts (DRUT1!'10ND, DUNCAN and HERTZMAN, 1966; 
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H.AI'11'1ERI1EISTER, YUNIS and KREBS, 1965) and 
in dog hearts (N.AI'11'1 and MAYER, 1967). 
Activation of isolated non-active 
phosphorylase b kinase can be achieved in 
various ways, namely (a) by incubation 
with trypsin (b) by addition of Mg++, ATP 
and cyclic AMP or (c) of ca++. Low con-
centrations of trypsin cause powerful acti-
vation of purified muscle phosphorylase b 
kinase, with a rise in enzyme activity at 
pH 6,8 and at pH 8,2 (KREBS, LOVE, BRATVOLD, 
TRAYSER, MEYER and FISCHER, 1964). Prein-
cubation with ATP and Mg++ ions activates 
rabbit skeletal phosphorylase b kinase and 
although this activation is enhanced by the 
addition of cyclic AMP, it does not appear 
to be essential (KREBS, GRAVES and FISCHER, 
1959; KREBS, LOVE, BRATVOLD, TRAYSER, MEYER 
and FISCHER, 1964). The same observations 
were made with bovine heart phosphorylase b 
kinase (DRUI11'10ND, DUNCAN and FRIESEN, 1965; 
DRUMMOND and DUNCAN, 1966; HAMMERI1EISTER, 
YUNIS and KREBS, 1965) and the human muscle 
enzyme (HANABUSA and KOBAYASHI, 1967). 
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Activat~on by ATP was found to be speci-
fic. No activation took place with any of 
the following nucleotides tested together 
with Mg++: 5'-A11P, 3'-A11P, cyclic 3' ,?'-
AMP, CMP, CDP, CTP, UMP, UDP, UTP, GMP, GDP, 
GTP, IMP, IDP and ITP (KREBS, LOVE, BRATVOLD, 
TRAYSER, MEYER and FISCHER, 1964). 
A protein kinase, which is cyclic A11P-
dependent has been purified from rabbit brain 
(MIYAMOTO, JUO and GREENGARD, 1969) and rabbit 
skeletal muscle (WALSH, PERKINS and KREBS, 1968). 
This protein kinase phosphorylates proteins 
such as casein and protamine, and also expe-
dites the rate of activation and phosphorylation· 
M ++ • . 
of phosphorylase b kinase by ATP and 11g ions. 
Since the activity of this kinase is entirely 
dependent on cyclic AMP, it seems likely that 
this enzyme is involved during epinephrine 
stimulation of adenyl cyclase, which catalyzes 
the conversion of ATP to cyclic A11P, and in 
turn activates phosphorylase b kinase. The 
proposed name for this protein kinase is 
phosphorylase kinase kinase (WALSH, PERKINS 
and KREBS, 1968). The phosphorylation-
dephosphorylation process which activates 
phosphorylase b kinase is of physiological 
importance since it is reversible. 
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Non-activated phosphorylase b kinase 
can be activated by incubation with Ca++_ 
ions. This activation is not reversible. 
In the phosphorylase b to~ reaction itself, 
ca++ is a competitive inhibitor with respect 
to Mg++ (KREBS, GRAVES and FISCHER, 1959). 
Activation of rabbit skeletal muscle phos-
phorylase b kinase by incubation with Ca++ 
was found to require an additional protein 
factor, the kinase activating factor (KAF). 
This process is also not reversible, as by 
chelation of Ca++ with EDTA. S ++- dB++ r an a 
were also found to be activators of phospho-
rylase b kinase. KAF has been purified 700 
fold and was then observed to have no protea-
lytic activity. Purified KAF is very unstable 
in the presence of ca++, and about 50% of its 
activity was lost on incubation at 30°c with 
0, 015M Ca +i+. In the presence of EDTA, how-
ever, KAF can be stored frozen without loss 
of activity (MEY.ER, FISCHER and KREBS, 1964). 
KAF purified from rabbit skeletal muscle was 
subsequently observed to possess proteolytic 
activity (HUSTON and KREBS, 1968). In the 
presence of Ca++, KAF causes enzyme activation 
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and release of peptides. This proteolytic 
action of KAF in the presence of Ca++ and 
the irreversibility of the activation of 
phosphorylase b kinase makes it unlikely 
that this mechanism is of any physiological 
importance. 
Nonetheless, OZAWA, HOSOI and EBASI, 
'1967, remarked that activation of phosphory-
lase b kinase of rabbit skeletal muscle by 
ca++ ions alone was reversible. Free Ca++ 
ions at a concentration of '10-7M generated 
more than half the maximum activity. This 
observation suggests that phosphorylase b 
kinase could be stimulated by Ca++ ions re-
leased from the sarcoplasmic reticulum under 
physiological conditions. 
A kinase inhibitory factor, which pre-
vents activation by ca++, has been isolated 
from beef heart and purified. The action 
of the kinase inhibitory factor appears to 
be non-catalytic (DRUMMOND and DUNCAN, '1966). 
The role of ca++ activation has been 
studied in a rabbit muscle protein-glycogen 
complex, containing glycogen granules, and 
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fragments of the sarcoplasmic reticulum to 
which are attached phosphorylase, phospho-
rylase kinase, phosphorylase phosphatase 
and other enzymes (HEIL1'1EYER, 1'1EYER, HASCHKE 
and FISCHER, 1970). This fraction contained 
phosphorylase in its inactive b form, since 
the phosphorylase kinase present was inactive 
and phosphorylase phosphatase fully active. 
Upon the addition of Mg++, ATP and Ca++ 
phosphorylase kinase was activated and phos-
phorylase b was converted to phosphorylase a. 
No activation was achieved with Mg++ and ATP 
alone. Depletion of ATP in the system led 
to reconversion of phosphorylase a to phospho-
rylase b by phosphorylase phosphatase. On 
addition of ATP, the whole cycle was repeated, 
being known as the "flash activation" of 
phosphorylase. Activation by Ca++ was revers-
ible by addition of chelating agents and could 
not, therefore, be due to proteolytic attack 
by the calcium-dependent KAF. The concentra-
tion of free calcium required for half-maximum 
activation of phosphorylase kinase in this 
system was 2 x 10-6M. For purified systems, 
the concentration of ca++ needed was 10-7M, 
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the same concentration that is required to 
initiate muscle contraction. 
The affinity of phosphorylase kinase for 
phosphorylase b was magnified 13-fold during 
C ++ t· t· a -ac iva ion. No evidence could be eli-
cited as to whether activation of phosphory-
lase kinase by ca++ was accompanied by phos-
phorylation. In the absence of ca++, and 
in the presence of Mg++, ATP and cyclic AMP, 
only slight activation of phosphorylase was 
observed. The elegant studies of Ebashi and 
his colleagues appear firmly to have established 
the physiological role of ca++ as an activator 
or regulator of glycogenolysis at the phospho-
rylase step. ca++ is thus the link coupling 
activation of the contractile mechanism and 
the breakdown of glycogen which can supply 
anaerobic energy for such contraction. 
Skeletal muscle and other tissues contain 
a phosphatase that catalyzes the dephosphoryla-
tion of activated phosphorylase kinase. This 
phosphatase, designated as phosphorylase kinase 
phosphatase, is activated by metal ions and in-
hibited by sodium fluoride (RILEY, DE LANGE, 
BRATVOLD and KREBS, 1968). 
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(iii) The conversion of phosphorylase a 
to phosphorylase b. 






2 PHOSPHORYLASE b + 4P. 
l 
(GRAVES, FISCHER and KREBS, 1960). 
Rabbit skeletal muscle and other tissues 
contain an enzyme which catalyzes the conver-
sion of phosphorylase a to phosphorylase b 
(CORI and GREEN, 1943) and the conversion is 
accompanied by a halving in the molecular 
weight (KELLER and CORI, 1953). This enzyme 
was orignally designated "PR-enzyme" because 
it was thought to function as a prosthetic 
group-removing enzyme. The PR-enzyme was 
thought to cleave a prosthetic group from 
phosphorylase a, which contained Al'1P (CORI 
and GREEN, 1943). However attempts to de-
monstrate that Al'1P was detached during the 
conversion of phosphorylase a to b were un-
successful. There is no evidence that Al'1P 
appears among the products (CORI and CORI, 
1945; VELICK and WICKS, 1951). 
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The PR-enzyme was partially purified 
from rabbit skeletal muscle and some of its 
properties were determined (CORI and CORI, 
1945; KELLER and CORI, 1955). The activa-
ty of this enzyme was boosted by the presence 
of cysteine, inhibited by sodium fluoride and 
no stimulation was observed with Mn++, Mg++ 
C ++ . or a ions. Synthetic substrates of 
trypsin inhibited the PR-enzyme and it was 
suggested that it might be a proteolytic 
enzyme (KELLER and FRIED, 1955). 
Later it was observed that change of 
phosphorylase a into b was accompanied by a 
release of inorganic phosphate (RALL, WOSI-
LAIT and SUTHERLAND, 1956; FISCHER, GRAVES 
and KREBS, 1957) and the name phosphorylase 
phosphatase was proposed for the PR-enzyme 
(WOSILAIT and SUTHERLAND, 1956). 
Phosphorylase a phosphatase activity can 
be regulated by reversible mechanisms of acti-
vation and inactivation. Preincubation of 
partially purified phosphorylase a phosphatase 
from bovine adrenal cortex in the presence of 
ATP and Mg++ raises the activity of the enzyme. 
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Incubation of activated phosphorylase a 
phosphatase in the presence of ATP inactivated 
the enzyme. Addition of cyclic .Al'1P, as well 
as ATP and Mg++, converted the active form 
into a less active one (MERLEVEDE and RILEY, 
1966). Evidence was adduced that a similar 
mechanism operates in pigeon breast muscle 
(CHELALA and TORRES, '1969) and in dog liver 
(MERLEVEDE, GORIS and DE BRANDT, 1969). 
There is thus a system of control of inactiva-
tion and activation of phosphorylase ~ phospha-
tase analogous to that for phosphorylase b 
kinase. These two systems, dependent on 
activation and inhibition by nucleotides, are 
linked in such a manner that when one system 
is potentiated the other is inhibited and vice 
versa in a reciprocal manner. 
After many inconclusive studies, a glycogen 
particle has finally been characterised. A 
protein-glycogen complex was isolated from 
rabbit muscle, which contained glycogen granules 
and fragments of the sarcoplasmic reticulum (SR) 
to which were attached phosphorylas~, phosphory-
lase kinase, phosphorylase phosphatase and other 
enzymes (MEYER, HEILMEYER, HASCHKE and FISCHER, 
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1970). It was established that phosphorylase 
phosphatase included within this protein com-
plex undergoes a reversible inhibition when 
phosphorylase is activated. This inhibition 
requires free Ca++ in addition to Mg-ATP, the 
same conditions that promote phosphorylase 
activation. Inhibition is only observed in 
the intact protein-glycogen complex. It was 
also established that .the inhibition was not 
caused by AMP or IMP generated from the break-
down of ATP. AMP and IMP are known to inhibit 
phosphorylase a phosphatase by binding to the 
substrate., phosphorylase a (NOLAN, NOVOA, KREBS 
and FISCHER, '1964). Dissociation of the 
protein-glycogen complex by dilution leads to 
ca++_stabilization of phosphorylase a phospha-
tase with respect to Ca++ and a reappearance 
of its sensitivity towards AMP or IMP. 
There is no evidence that changes occur 
in the enzyme during the process of inhibition 
and it is thought that inhibition results from 
interaction of phosphorylase a phosphatase with 
some of the other components of the phosphory-
lase system. 
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The activity of phosphorylase a phospha-
tase is amenable to alteration in a manner 
which suggests that the enzyme could play an 
active role in the regulation of glycogen 
phosphorylase (HASCHKE, HEILJ'1EYER, MEYER and 
KREBS, '1970). 
D. PHQSPHOFRUCTOKINASE (PFK) 
PFK is the enzyme which catalyzes the 
reaction: 
I'1g++ 
FRUCTOSE-6-PHOSPHATE + ATP ~~f> FRUCTOSE-'1,6-
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DIPHOSPHATE + ADP 
The reaction is not significantly reversible. 
The reverse reaction is catalyzed by another 
enzyme, fructose-'1,6-diphosphatase. PFK is 
now well established as a rate-limiting enzyme 
in glycogenolysis. The PFK step can either be 
activated or inhibited. 
Rate limiting steps in the glycolytic 
pathway can be traced by applying the crossover 
theorem (CHANCE, HOLMES, HIGGENS and CONNELLY, 
'19 58). Evidence for enzyme activation is based 
on a fall in the concentration of the substrate 
and a rise in that of the product of the reac-
tion. Inhibition is based on an accumulation 
of the substrate and a decline in the concentra-
tion of the products of the reaction. 
In the PFK system, a crossover is observed 
between fructose-6-phosphate and fructose-1,6-
di phosphate. An increased forward flux,. lower-
ing of fr~ctose-6-phosphate and a rise in 
fructose-1,6-diphosphate due'to activation of 
PFK is witnessed, and a decreased backward flux, 
concomitant increase in fructose-6-phosphate and 
fall-off in fructose-1,6-diphosphate is ascribable 
to inhibition of PFK. 
According to these criteria, an increased 
flux due to PFK activation has been observed 
during (i) carbon monoxide-induced anoxia in 
rat heart (WILLIAMSON, 1966) (ii) alkalosis 
in the isolated rat heart (SCHEUER and BERRY, 
1967) (iii) ischaemia of mouse brain (LOWRY, 
PASSONNEAU, HASSELBERGER and SCHULZ, 1964) 
(iv) muscular contraction in frog skeletal 
II 
muscle ( OZAND and NARAHARA, 1964} (v) insulin 
II 
.administration to frog skeletal muscle (OZAND 
and NARAHARA, 1964) (vi) exposure of mice to 
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the convulsant, Indoklan ["bis ( 2, 2, 2-
trifluoroethyl ether)] (SACKTOR, WILSON and 
TIEKERT, 1966) (vii) in the blowfly, 
Phormia regina,during flight (SACKTOR and 
. WORJVISER-SHAVIT, 1966) (viii) during per-
fusion of rat heart with glucose, insulin and 
iodoacetamide (WILLIAMSON, 1967) and (ix) during 
electrical discharge of the electric organ of 
Electrophorus electricus (WILLIAl"ISON, CHEUNG, 
COLES and HERCZEG, 1967). 
A decreased forward flux has been observed 
(i) during perfusion of rat heart with glucose, 
insulin and fluoroacetate (WILLIAl"ISON, 1967), 
(ii) with acetate and pyruvate (WILLIAMSON, 
1965), or with.fatty acids (GARLAND, RANDLE and 
NEWSHOLI1E, 1963; PARJVIEGGIANI and BOWI'1AN, 1963). 
All observations are consistent with activation 
of phosphofructokinase in conditions of enhanced 
glycolytic flux and vice versa. 
PFK has been isolated and purified from 
guinea pig heart (MANSOUR, 1963), from rabbit 
muscle (PARMEGGIANI and KREBS, 1965; LING, 
MARCUS and LARDY, 1965) and from sheep heart 
(MANSOUR, WAKID and SPROUSE, 1966). Storage 
of the crystallized rabbit muscle PFK in the 
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presence of ATP prevents the enzyme from 
aggregating (PAR.MEGGIANI, LUFT, LOVE and 
KREBS, 1966). 2M NaCl caused dissociation 
of sheep heart PFK, accompanied by a decline 
in its catalytic activity (MANSOUR, WAKID 
and SPROUSE, 1966). 
Incubation of rabbit skeletal muscle PFK 
with 5,-5'-dithiobis(2-nitrobenzoic acid) 
(DTNB) at pH 8,0 leads to a reaction with 
seven to eight cysteinyl residues per 105g 
of enzyme. At pH 7,0 approximately three 
thiol groups react rapidly with DTNB whilst 
the remaining four to five react slowly. 
By reaction of the first three -SH groups 
with DTNB, 90 - 95% of the enzyme activity 
is lost. In the presence of fructose-6-
phosphate or adenine nucleotides, however, 
only one cysteinyl residue is highly reactive 
and there is, consequently, only a slight de-
pression of the enzyme activity. Even after 
further reaction with the ·other four to five 
less reactive cysteinyl residues, enzyme acti-
vity is still retained. Glucose-6-phosphate, 
GMP and IMP do not possess the protective 
capacity of fructose-6-phosphate and other 
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adenine nucleotides (KEMP and FOREST, '1968). 
It transpires that PFK is a sulphydryl enzyme 
but that the reactive -SH groups can be protec-
ted by cofactors or substrate. A Mg-ATP com-
plex also guards the rapidly reactive -SH 
groups of rabbit skeletal.muscle PFK against 
attack by DTNB, through interaction with the 
inhibitory site on the enzyme (KEMP, '1969). 
ATP and citrate are proven potent inhipi-
tors of PFK, whilst ADP, AMP, cyclic AMP, 
inorganic phosphate, fructose-6-phosphate, 
fructose-'1,6-diphosphate, ammonia and glucose-
'1,6-diphosphate are activators. 
PFK from different tissues has exhibited 
many similarities in behaviour towards these 
inhibitors and activators. 
Cyclic AMP ('10-~) stimulates PFK activity 
in homogenates of guinea pig heart (MANSOUR, 
CLAGUE and BEERNINK, '1962). Extent of activa-
tion is inversely proportional to fructose-6-
phosphate concentration. Cyclic AMP also 
partially protects PFK from inhibition by an 
excess of ATP. AMP and inorganic phosphate 
also activate the enzyme. ATP in concentra-
tions greater than optimal inhibits PFK. 
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Incubation of the intact liver fluke with 
serotonin results in an increase of glycolysis, 
due to the increase of PFK activity (MANSOUR, 
1962). Cyclic Al'1P (10-5M) in this organism 
provokes a striking response in PFK. The 
stimulatory process requires the presence of 
both ATP and Mg++ ions. Activation due to 
cyclic Al'1P is inversely proportional to the 
concentration of fructose-6-phosphate. ATP 
in concentrations higher than optimal inhibits 
PFK (MANSOUR and MANSOUR, 1962), and cyclic 
Al'1P is protective against ATP under these con-
ditions. This is an interesting example of 
enzyme inhibition by a necessary cofactor or 
substrate. 
PFK can be isolated from rabbit skeletal 
muscle in two different forms, one containing 
nucleic acid and one that is free of nucleic 
acid. These two isoenzymes have different 
affinities for citrate, Al'1P, inorganic phosphate 
and fructose-1,6-diphosphate (HOFER and FETTE, 
1966). 
Rabbit muscle PFK is inhibited by ATP and 
stimulated by inorganic phosphate, Al'1P, ADP, 
fructose-6-phosphate and fructose-1,6-diphosphate. 
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Apparently, there are two sites of attacbment 
for ATP, a primary active site and a second 
inhibitory site. The stimulators or activa~ 
tors can thus compete with ATP for the second 
site (PASSONNEAU and LOWRY, 1962). 
The mode of binding of metabolites by 
rabbit skeletal muscle PFK has been studied 
by the gel filtration technique. ADP, cyclic 
AMP and AMP were bound competitively to PFK 
with dissociation constants of 0,5, 0,6 and 
1,8 !l.11'1 respectively. The dissociation con-
stant of cyclic AMP bound to enzyme is lowered 
by the presence of fructose-6-phosphate and 
fructose-1,6-diphosphate. 
Binding of PFK to fructose-6-phosphate, 
AMP, ADP and cyclic AMP indicated a molar bind-
ing unit of 90 000 daltons for these compounds, 
but three moles of ATP were bound by this quan-
tity of enzyme. ATP inhibits the binding of 
fructose-6-phosphate and this inhibition was 
relieved by inorganic phosphate. Citrate 
enhances the affinity of PFK for ATP and weakens 
the affinity of the enzyme for AMP and fructose-
6-phosphate (KEMP and KREBS, 1967). 
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Isoenzymes of PFK in E. coli (ATKINSON 
and WALTON, 1965), in sheep brain and in rat 
liver (PASSONNEAU and LOWRY, 1963) exhibit 
essentially similar patterns of inhibition 
and stimulation. Yeast PFK, however, does 
react somewhat differently in that incubation 
of the enzyme with trypsin renders it insensi-
tive to ATP (SALAS, SALAS and SOLS, 1968). 
Many other phosphorylated intermediates have 
been studied, including creatine phosphate 
and 3-phosphoglycerate and the latter has been 
recognised to be the most potent inhibitor of 
PFK isolated from rabbit brain (KRZANOWSKI and 
MATSCHINSKY, 1969) ·• 
Partially purified preparations of PFK 
from guinea pig heart, when incubated at pH 
5,8, lose activity reversibly. The inactive 
enzyme can be revivified in an alkaline pH. 
Reactivation is expedited by the following 
nucleotides and hexose phosphates; ATP, ADP, 
AMP, fructose-6-phosphate and fructose-1,6-
diphosphate. A mixture of a nucleotide with 
a hexose phosphate is much more effective in 
reactivation of PFK than either nucleotide or 
hexose phosphate alone (MANSOUR, 1965). The 
-4-5-
enzymic activity of PFK of the skeletal muscle 
from frog and mouse is extremely sensitive to 
small changes in pH in the physiological range. 
A low pH weakens the affinity of the enzyme for 
fructose-6-phosphate. Shifts in intracellular 
pH may be important in the regulation of PFK 
activity (TRIVEDI and DANFORTH, 1966). A fall 
in intracellular pH is likely to inhibit PFK 
and glycolysis would tend,therefore, to be 
self-limiting. On the other hand, its pH 
dependence could be invoked to explain the 
tendency towards lactacidosis observed during 
alkalosis in man (GEVERS and DOWTILE, 1963). 
E. PYRUVATE KINASE (PK) 
Pyruvate kinase (PK) catalyzes the reaction 
PYRUVATE KINASE 
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PHOSPHOENOLPYRUVATE + ADP· l;>PYRUVATE + ATP 
K+; Mg++ 
(LARDY and ZIEGLER, 1945). 
Rabbit muscle PK has a molecular weight of 
237 000 daltons. It is a tetramer, containing 
four polypeptide chains, each with a molecular 
weight of 57 200. PK is regarded as consisting 
of two identical catalytic units or protomers, 
each with a molecular weight of 115 000, each 
protomer in turn comprising two polypeptide 
chains, each with a molecular weight of 57 000. 
++ 
Each protomer has a single site for Mn and 
phosphoenolpyruvate. There.is also speculation 
that the two polypeptide chains within a proto-
mer might not be identical, despite their simi-
larity in molecular weight. Treatment with 
urea revealed intermediates with a sedimentation 
rate of 7,3S in 1,5M urea and particles of 3,6S 
in 3M urea (STEINMETZ and DEAL, 1966). 
Potassium acts as a potent activator of 
bb ·t 1 PK db th Rb++ d NH+ ra i muse e , an o an 4 can 
replace K+ in this role. Although Na+ is a 
weak activator, Li+ has no or little adjuvant 
capacity. Both Na+ and Li+ were found to oppose 
the action of K+ (KACHJVIAR and BOYER, 1953). 
The presence of ADP is also obligatory for the 
PK reaction (HARRISON, BOYER and FALCONE, 1955). 
Mg++ has been found to be an activator of PK 
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of mammalian erythrocytes, and can be partially 
replaced by Mn++ or Co++ (SOLVONUK and COLLIER, 
1955). 
PK, purified from mammalian erythrocytes, 
requires free thiol functions for its activity. 
Complete inhibition of PK is observed on addi-
tion of 10-4M p-CMB and this inhibition can be 
partially revoked by glutathione (SOLVONUK and 
COLLIER, 1955). In rat muscle, inorganic phos-
phate and Na+, in relative high concentrations, 
inhibit the transfer of ~hosphate from phospho-
enolpyruvate to ADP (BOYER, LARDY and PHILLIPS, 
1943). 
Low concentrations of Ca++ in rabbit muscle 
prevent the activation of PK by K+. Approxi-
mately 50% inhibition was observed in the 
presence of 0,05M K+ and 0,002M Ca++. Raising 
the concentration of K+,however, partly reversed 
the inhibition by Ca++ (KACHMAR and BOYER, 1953). 
The negatory effect of Ca++ is due to prohibition 
of the transfer of phosphate from phosphoenolpyru-
vate to ADP (BOYER, LARDY and PHILLIPS, 1943), 
and is competitive with Mn++ and Mg++ (MILDVAN 
and COHEN, 1965). 
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ATP also inhibits PK, and this inhibition 
is competitive with phosphoenolpyruvate (BOYER, 
1969), from the fact that their transferable 
phosphate groups bind to the same site on PK 
(REYNARD, HASS, JACOBSEN and BOYER, 1961). 
Partially purified erythrocyte PK can be 
stabi·lized by l"Ig++, 2-mercaptoethanol and in-
organic phosphate. Phosphoenolpyruvate was 
found to be much more effective for this than 
ADP or inorganic phosphate. Ethylenediamine-
tetraacetic acid (EDTA) impaired this stabilizing 
effect, maybe due to chelation of the l"Ig++ ions. 
This isoenzyme was much more stable below pH 7,4 
than above, and the optimum pH lay between pH 
6,8 and pH 7,1 (IBSEN, SCHILLER and VENN-WATSON, 
1968). 
Rat epididymal adipose PK exists in two 
interconvertible forms, designated as PK-A, 
which is activated by fructose-1,6-diphosphate, 
and PK-B which is insensitive to fructose-1,6-
diphosphate (POGSON, 1968 (a) and (b)). PK-A 
can be converted to PK-B by incubation with low 
concentrations of fructose-1,6-diphosphate and 
this process is reversible by incubation with 
EDTA, ATP and citrate which compete with 
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fructose-1,6-diphosphate. During active 
glycolysis, this enzyme is normally present 
in the PK-B form. Incubation of epididymal 
fat pads with glucose and insulin provides 
evidence that the equilibrium under surveil-
lance of Pk·. in this tissue is far displaced 
towards pyruvate, and PK· serves as a control 
point during glycolysis. 
There are two types of PK present in 
mammalian tissues, namely type Land type M. 
The M type is present in muscle, brain, heart,· 
liver and kidney, but the L type is present 
only in kidney and liver (TANAKA, HARANO,- MORII1URA 
and MORI, 1965). Crystalline L type from 
rat liver can be activated by fructose-1,6-
diphosphate or phosphoenolpyruvate, and inhibi-
tion by ATP was markedly alleviated by the 
presence of fructose-1,6-diphosphate. The M 
type on the other hand did not respond signifi-
cantly to the presence of fructose-1,6-diphosphate. 
The reaction rate of PK in rat liver can therefore 
be controlled with fine precision, in vivo, by 
the presence, in varying concentrations, of ATP, 
phosphoenolpyruvate and fructose-1,6-diphosphate 
(TANAKA, SUE and MORI1'1URA, 1967). The L type 
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PK of mice is strongly inhibited by cu++, but 
this inhibition was also reversible by the 
addition of fructose-1,6-diphophate. The M 
isoenzyme was only slightly or not at all 
affected by Cu++ (PASSERON, DE ASUA and 
CAR1'1INATTI, 1967). 
Studies with rat liver PK in vitro also 
indicate a maximal activation of the enzyme 
when it is saturated with certain concentra-
tions of NADH. However, if the NADH concen-
tration is further raised (> 0. 3 N1I1oles/ml 
reaction mixture), PK is gradually inactivated 
and activity approaches zero. If this inter-
action operates in vivo, it could provide a 
mechanism for switching off PK when lactate 
is converted into pyruvate during gluconeogene-
sis (WEBER, SINGHAL, STAJ'111 AND SRIVASTAVA, 
1965). The rate of change of lactate to 
pyruvate within the liver, part of the Cori 
cycle of lactate, will, of course, be of 
supreme importance in conditions giving rise 
to lactate acidosis. The theme of this the-
sis, Malignant Hyperthermia, provides a situation 
in which generation of NADH by the lactate 
dehydrogenase system will be amplified many 
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fold as compared with the resting state. 
Studies with rat liver PK have also proven 
that triamcinolone, a steroid and potent 
stimulator of gluconeogenesis, is without 
effect on hepatic PK. PK activity in dia-
betes and the response of the enzyme to 
insulin have also been studied. When 
alloxan-diabetes was induced by intraperi-
toneal injection, it was noted that activity 
of PK fell to 60% at 24 hours and to 30-40% 
at 144 hours after induction of diabetes 
(WEBER, ST.AI111 and FISHER, 1965). At this 
stage, insulin had almost disappeared from 
the alloxan-treated rat. To investigate 
the action of insulin on these diabetic rats, 
insulin was injected, and it was observed that 
PK activity was then restored to normal, due 
to synthesis of new enzyme induced by the 
action of insulin. 
Dietary cond.i tions also play a role in 
the regulation of activity of the PK enzyme 
(KREBS and EGGLESTON, 1965). On changing 
from a standard diet to a low carbohydrate 
diet, enzyme activity declined to about one 
third, and on a.high carbohydrate diet, the 
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activity rose to more than three fold. When 
the diet was low in carbohydrates or du.ring 
starvation, gluconeogenesis occurs on a major 
scale, and PK activity is correspondingly low, 
and the conversion of phosphoenolpyruvate to 
pyruvate is retarded or abated completely. 
On the other hand, when the diet is riqh in 
carbohydrates, PK activity is greatly raised 
and this promotes the conversion of phospho-
enolpyruvate to pyruvate, which, in turn, is 
decarboxylated to acetyl CoA, which can either 
be oxidized in the citric acid cycle or be 
utilized for synthesis of fatty acids. The 
activity of PK reaches a maximum, on this 
regime, only after a few days have elapsed, 
from which it is inferred that the augmented 
activity stems from a more rapid rate of enzyme 
synthesis. This alteration in PK activity 
provides an important regulatory device for 




M E T H O D O L O G Y 
I. EXPERIMENTAL MODEL 
Pigs known to be susceptible to halothane, 
on the grounds either of previous exposure or 
of an observed elevated plasma creatine phospho-
kinase activity, were anaesthetised with pento-
thal intravenously and intubated. Anaesthesia 
was maintained with intravenous pentothal and 
nitrous oxide/oxygen (80/20 v/v). Adductor 
magnus, a muscle in the groin, was exposed and 
longitudinal strips were carefully freed from 
the underlying tissue and string ligatures were 
placed loosely round their proximal and distal 
ends. 
At time O, halothane 3% v/v was introduced 
into the inhalation circuit. None of the pigs 
in this series reacted to halothane alone. 
Between 10 and 15 minutes later, 2 mg succinyl 
choline was administered intravenously. All 
animals experienced a rapid rise in body tempera-
ture to 42 or 43°C within 20 minutes. Pigs 
22B and 139 developed rigor which was sustained 
until death 30-40 minutes later. This rigor 
persisted unchanged into post-mortem. Pig 137 
was anomalous in that although hyperpyrexia 
-54-
ensued, there was no rigor and lactacidosis 
was less severe (see Results). 
II. ENZYMES 
Fructose-1,6-diphosphate aldolase was 
obtained from Boehringer and Soehne GmbH, 
Mannheim, Germany. Creatine phosphokinase, 
enolase, glucose-6-phosphate dehydrogenase, 
oc-glycerophosphate dehydrogenase, myokinase, 
malic dehydrogenase, phosphoglucose isomerase, 
phosphoglucomutase, phosphoglycerate mutase, 
pyruvate kinase and triosephosphate isomerase 
came from Sigma Chemical Company, St. Louis, 
U.S.A. Hexokinase and lactic dehydrogenase 
were products from Seravac Laboratories, Cape 
Town. 
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III. PREPARATION OF TISSUE EXTRACTS 
PCA extracts were prepared according to 
WILLI.Al'1SON, 1965. Samples of skeletal mus-
cle were frozen within 5 to 8 seconds after 
removal by immersing immediately into liquid 
nitrogen. The frozen tissue was powdered 
in a stainless steel percussion mortar, which 
had been cooled in liquid nitrogen. The 
powdered tissue was transferred into a pre-
weighed McCartney bottle containing cold PCA 
o., 6N which was kept in ice. The McCartney 
bottle was weighed again to obtain the weight 
of the tissue. For each gram of tissue, 4 
volumes of PCA (0,6N) was added. The tissue 
was homogenized for a few seconds in the cold 
(4°C) with an Ultra Turrax homogenizer. The 
mixture was transferred into a centrifuge tube 
and centrifuged at 15 000 x g for 15 minutes 
in a refrigerated Sorvall RC-2B centrifuge. 
The volume of supernatant was measured and 
the pH adjusted to 6,0 by addition of K2co3 
(3,0N), the volume of K2co3 needed being re-
corded. The·potassium perchlorate precipitate 
was removed by centrifugation at 15 000 x g for 
15 minutes in a refrigerated Sorvall RC-2B 
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centrifuge. Extracts were kept frozen if 
not used immediately. The least stable 
glycolytic intermediates such as pyruvate, 
phosphoenolpyruvate, 2-phosphoglycerate, 
3-phosphoglycerate were analyzed on the day 
of extraction. The other glycolytic inter-
mediates and cofactors were measured over a 
period of days. 
IV. QUANTITATION OF GLYCOLYTIC INTER-
MEDIATES BY MEANS OF ENZYMATIC 
NUCLEOTIDE~LINKED REACTIONS. 
A. PRINCIPLES OF METHODS 
Measurements were based on the principle 
of (i) a decrease in O.D. at 340 nm due to 
the oxidation of NADH to NAD or (ii) a rise 
in O.D. at 340 nm due to the reduction of NADP 
to NADPH or NAD to NADH. The change in O.D. 
was measured spectrophotometrically in a Zeiss 
PMQII spectrophotometer. Because of their low 
concentrations, dihydroxyacetone phosphate and 
glyceraldehyde-3-phosphate were determined 
-57-
fluorometrically. Fluorometric measurements 
were made in a Hitachi Perkin-Elmer Fluores-
cence Spectrophotometer MPF-2A. Excitation 
was at 340 nm and emission was set at 420 nm. 
The substrates, fructose-1,6-diphosphate, 
2-phosphoglycer1c acid, 3-phosphoglyceric acid, 
phosphoenolpyruvate, adenosine-5'-monophosphate 
and adenosine-5'-diphosphate were quantitated 
by following the oxidation of NADH. 
Reduction of NAD+ was used to measure 
lactate, o<:-glycerophosphate, malate, dihydroxy-
acetone phosphate and glyceraldehyde-3-phosphate. 
Reduction of NADP, coupled with glucose-6-
phosphate dehydrogenase, provided the basis for 
determinations of glucose-1-phosphate, glucose-






GLUCOSE-6-PHOSPHATE and FRUCTOSE-6-PHOSPHATE 
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Glucose-6-phosphate is oxidized by NADP 
and glucose-6-phosphate dehydrogenase to 6-
phosphogluconic acid. The equilibrium of 
this reaction lies far to the right, that is, 
















Glucose-1-phosphate is converted to glucose-
6-phosphate under the influence of the enzyme 
h h 1 t • th f M ++ • p osp og ucomu ase in e presence o ug ions. 
The glucose-6-phosphate is oxidized according to 





Fructose-6-phosphate is converted to 
glucose-6-phosphate with the aid of phospho-
glucose isomerase, and glucose-6-phosphate 
again proces:"$ed according to equation "\,_page 
59. 
DETER1'1INATION OF FRUCTOSE-1,6~DIPHOSPHATE, 
DIHYDROXYACETONE PHOSPHATE AND 
GLYCERALDEHYDE-3-PHOSPHATE. 
II 




C=O + NADH 
I 
GLYCEROPHOSPHATE CH2-0-P03H2 



























Fructose-1,6-diphosphate aldolase cleaves 
fructose-1,6-diphosphate between carbon 3 
and 4 to give two triose phosphates, 
glyceraldehyde-3-phosphate and dihydroxy-
acetone phosphate. 

















For each molecule of fructose 1,6-diphosphate, 
2 molecules of NADH are oxidized to 2NAD+. 
DETERMINATION OF oC-GLYCEROPHOSPHATE 
(HOHORST, 1965 (c)) 
Principle: 
( 1) CH2-0-P03H2 £-GLYCEROPHOSPHATE I + DEHYTIROGENASE , 























The equilibrium of the above reactions lies 
far to the left, in the direction of the forma-
tion of oe-glycerophosphate. The reaction product, 
dihydroxyacetone phosphate, must therefore 
be removed continuously for the reaction to 
proceed. Protons formed are bound by an 
alkaline medium, and the reaction product·, 
dihydroxyacetone phosphate, is trapped as 
dihydroxyacetone phosphate hydrazone. 
-65-
DETER1'1INATION OF 3-PHOSPHOGLYCERATE, 
2-PHOSPHOGLYCERATE, PHOSPHOENOLPYRUVATE 
AND PYRUVATE. 
(CZOK and ECKERT, 1965) 
Principle: 
The substrates 3-phosphoglycerate, 2-
phosphoglycerate, phosphoenolpyruvate and 













































C=O + NADR + R+ ~~~~~~~-
COOR 
I 









3-phosphoglycerate can be determined by this 
method only if the assay mixture contains less 
than 10-3n inorganic phosphate. The inhibitory 
effect of phosphate can be diminished if the same 
volume of 1'1nS04 is added instead of MgS04 • 
Phosphate does not interfere with determination 
of 2-phosphoglycerate, phosphoenolpyruvate and 
pyruvate. 
DETERMINATION OF LACTATE 


































The equilibrium of reaction lies far to the 
left, that is, towards lactate. The reaction 
product pyruvate, must therefore, be removed from 
the reaction mixture, as fast as it is 
formed, to allow continuous oxidation of 
lactate. Protons are neutralized by 
having an alkaline medium, pH 9,5, and 
pyruvate is trapped as pyruvate hydrazone. 
-69-. 
DETERMINATION OF MALATE 








( 2) COOR 
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C=N-NH2 + NADH + H+ I 
COOR 
OXALOACETATE HYDRAZONE 
The equilibrium of the above reaction (1) 
also lies far to the left, that is, in the di-
rection of the formation of malate. The reac-
tion product, oxaloacetate, must therefore be 
removed for the reaction to proceed. The 
protons formed are removed into the alkaline 
medium, and the reaction product, oxaloace-
tate, is trapped as oxaloacetate hydrazone. 
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( '1 ) 
(2) 
AMP + ATP 
COOR 
I 
MY OKIN ASE 




2 C-O-P03R2 II 
+ 2 ADP 
PYRUVATE 
KINASE 2 C=O + 2 ATP ----- I 
CR3 CH2 
PHOSPHOENOLPYRUVATE PYRUVATE 
(3) COOH LACTIC COOH 
I DERYDROGENASE I 





AMP is phosphorylat_ed in the presence of 
ATP and myokinase to form two molecules of ADP. 
Phosphoenolpyruvate possesses a high energy 
phosphate bond which permits it to react with 
ADP to form ATP and pyruvate. The reaction is 
catalyzed by the enzyme pyruvate kinase which 
• M ++ d K+. requires ng an ions. 
+ 
2 NAD+ 
DETERI'1INATION OF CREATINE PHOSPHATE AND 
ADENOSINE-5'-TRIPHOSPHATE 
























The enzyme creatine phosphokinase catalyzes 
the transfer of the high energy phosphate .of 
creatine phosphate to ADP, to form creatine and 
ATP. ATP in turn phosphorylates glucose in the 
presence of hexokinase, to form glucose-6-phosphate, 
with the regeneration of ADP. Glucose-6-phosphate 
dehydrogenase catalyzes the oxidation of glucose-











GLUCOSE-6-PHOSPHATE + NADP+~~~~~~~~~~ 
6-PHOSPHOGLUCONO-~-LACTONE 
LAC TON ASE 
6-PHOSPHOGLUCONIC ACID+ NADPH + H+ 
(4) The overall reaction is: 
CREATINE PHOSPHATE+ GLUCOSE+ NADP+ ~~~~~~~ 
CREATINE + 6-PHOSPHOGLUCONIC ACID+ NADPH + H+ 
For each molecule of creatine phosphate 
decomposed, one molecule of NADPH is formed. 
Calculation of Results 
The following formula was applied to 
calculate the concentration of compounds 
originally present in sample of muscle. 
6ExV 
where 
6E = change in O.D. 340 nm 
V = volume of the assay mixture (ml) 
VD = volume of the PCA extract in the 
assay mixture (ml) 
d = light path of the cuvette (cm) 
~ = millimolar extinction coefficient 
of NADH or NADPH (/cm2/ pmole) 
f_ NADH(mM) = 6,22 
340 nm 
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DETERMINATION OF BLOOD LACTATE 
(HOHORST, ~965 (a)) 
Equal volumes of blood and of PCA were 
mixed in a glass-stoppered tube and centri-
fuged for 20 minutes at 2 000 x gin a re-
frigerated Sorvall RC-2B centrifuge. The 
supernatant fluid was removed. Lactate 
was measured enzymatically in the PCA extract 
as for muscle, but omitting precipitation of 
perchlorate. Owing to the relatively high 
concentration of lactate in serum, and the· 
small volume of extract which was added to 
the incubation mixture, the volume of PCA 
included was insufficient significantly to 
affect calculation of the activity of lactic 
dehydrogenase. 
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B. ASSAY PROCEDURES. 
Operative condit"ions in the various assays, 
such as total volume, concentration of buffer 
and cofactors, pH are given in Table I (pp. 78, 
79). Quantities of .enzyme were chosen which 
would achieve equilibrium within 3 to 5 minutes. 
Reactions were initiated by addition of the 
appropriate volume of enzyme solution and followed 
at 1 minute intervals until complete. It was 
found convenient to record re9ults and calcula-
tions on a duplicated sheet, a copy of which is 
reproduced in Fig. 5. In many instances, it 
was possible to determine substrates serially 
in the same reaction mixture by adding specific 
enzymes. The following were determined together 
(a) Glucose-6-phosphate, glucose-1-phosphate 
and fructose-6-phosphate. 
(b) Pyruvate, phosphoenolpyruvate, 2-phospho-
glycerate and 3-phosphoglycerate. 
(c) oC-glycerophosphate and malate. 
(d) ADP and AJ.VIP. 








































Conditions for assay of glycolytic intermediates and cofactors 
















mine, 0,05 M 
Triethanola-
mine, 0,05 M 
Triethanola-
mine, 0,05 M 
Triethanola-
mine, 0,4 M 
Triethanola-
mine, 0,4 M 
Triethano la-
mine, 0,4 M 
Hydrazine, 0,4 M 
Glycine, 1,0 M 
Triethanola-
mine, 0,2 M 
Triethanola-































































































TABLE I (Continued} -79-




Substrate extract Volume Path Buffer Buffer pH 
Cofactors Cofactors used 
Protein added 
ml. ml. cm. mM mM mg. 
Phosphoenolpyruvate 1,5 2,25 1 Triethanola- 44 7,6 NAfH 0,09 PK 0,2 




2,3-diPG 0, 11 
Pyruvate 1,5 2,25 1 Triethano la- 44 7,6 N.AJDH 0,09 LDH 0, 1 
mine, 0,2 M KCI 67 
MgS04 7,10 
ADP 0,22 
2;3-~iPG 0, 11 
I 
Lactate 0,05 2, 10 1 Hydrazine, 0,4 M 667 9,5 NAD 2,38 LDH 0, 1 
Glycine, 1, 0 M 
Malate ;J..,o 2, 10 1 Hydrazine, 0,4 M 667 9,5 NAD 2,38 MDH 0,025 
Glycine, 1,0 M 
Adenosine-5 1- 1,0 2,00 1 Triethano la- 215 7,55 N.AlDH 0,69 MK 0,005 





Adenosine-5 1- 1,0 2,00 1 Triethanola- 215 7,55 NADH 0,69 LDH 0,002 





Adenosine-5 1 - 0,1 5,24 2 Triethano la- 38 7,6 NADP 0,13 HK 0,05 -3 




Creati ne phosphate 0,1 5,24 2 Triethanola- 38 7,6 NADP 0,13 CPK 0,05 
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Such assays are feasible only with the use 
of pure enzymes. In every case, this was 
checked by failure of the enzyme to react 
with other than its own specific substrate. 
As an example, 0,01 ml (8,6 x 10-3 mg) of 
one preparation of glucose-6-phosphate de-
. . + 
hydrogenase, in the presence of NADP, was 
found to react with both glucose-6-phosphate 
and fructose-6-phosphate (Fig. 6, p. 83). 
The inference was that the enzyme was con-
taminated with significant quantities of 
phosphoglucose isomerase. However, 0,001 ml 
(8,6 x 10-4 mg) of the same preparation cata-
lyzed the dehydrogenation of glucose-6-phosphate 
at an acceptable rate. Reaction with fructose 
-6-phosphate was not appreciable when oxidation 
of glucose-6-phosphate had reached completion 
(Fig. 7, p. 84). 
Change in optical density observed during 
typical assays are shown in Fig. 8 (p. 85). 
Possible contribution to change in optical 
density by the enzyme preparation itself was 
allowed for in a blank determination (no PCA 
extract) and by adding the same volume of 
enzyme solution at the end of the reaction 
period and noting any increase in optical 
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density. Where significant, a correction 
was applied to 6E before final calculation 
of results. 
Pure standard substrates were not avail-
able for checking recovery in every instance 
and the e m1'1 value of 6, 22 was employed 
throughout. Assays were presumed to be 
satisfactory since, without exception, opti-
cal density changes of measurable magnitude 
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FIG. 6. DE TERM! NATION OF PURI TY OF G6P-DH FOR F-6-P ASSAY. 
DURING ASSAY PROCEDURE F-6-P, G6P-DH AND PG! ARE 
ADDED AS SHOWl'-1. MAJOR INCREASE IN 0.D. CX::CURRED 
BEFORE PG! WAS ADDED INDICATING CONTAMINATION OF 
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MIN. 
FIG. 7. EXPERIMENTAL PROCEDURE AS IN FIG. 6, BUT LESS G6P-DH USED. 
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MIN. 
FIG. 8. DETERMINATION OF PYRUVA TE, ADP AND AMP IN THE PCA EXTRACT 
OF MUSCLE (PIG 22 B; +12! MIN.) 
V. DETERMINATION OF GLYCOGEN 
, 

































Glycogen was extracted with trichloro-
acetic acid, precipitated with ethanol and 




Glucose was then determined.by the o-toluidine-
glucose coupling reaction, which is specific 
for the aldohexoses. Thiourea stabilizes 
the reagent, lowers the blank reading to al-
most zero and produces a pure green-blue 
II 
colour in the presence of glucose (HYVARINEN 
11 
and NIKKILA, 1962). 
Preparation of the TOA extract 
Muscle samples were frozen within 5 to 8 
seconds after removal by immersing immediate-
ly into liquid nitrogen. The frozen tissue 
was homogenized in cold TOA (10% w/v) with an 
Ultra Turrax homogenizer in the cold (4°0). 
The homogenate was brought to 30 ml per gram 
of tissue with 10% TCA, and centrifuged at 
1 000 x g for 10 minutes in a refrigerated 
Sorvall RC-2B centrifuge. 
Assay Procedure 
Absolute·ethanol (2 vol.) wo.S' added to 
2,0 ml of the supernatant, and the mixture 
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left overnight in the cold (4°C)o After 
centrifuging at 1 000 x g for 20 minutes 
in a refrigerated Sorvall RC-2B centrifuge, 
the supernatant was carefully decanted and 
the precipitate dried by placing the tubes 
in an inverted position on tissue paper. 
The precipitate was dissolved in 0,5 ml of 
The tubes, each stoppered with 
a marble, were transferred to a boiling 
water bath, and boiled for one hour. After 
cooling, 8,0 ml of o-toluidine reagent 
(toluidine (6% v/v) and thiourea (0,15% w/v) 
in glacial acetic acid) was added. The 
whole was well mixed and boiled again for 
B minutes. A green colour developed, and 
after cooling, the O.D. was measured against 
air at 635 nm." A blank and glucose standard 
containing 500 pg glucose in 2,0 N H2 so4 





X X = pmoles/ml 
V S'I1D 
M 2 (glucose equivalents) 
µMOLES/ML x DILUTION = JUI"lOLES/G. 
~ESTD = O.D. reading of the.standard 
VSTD = value of the standard(= 500 µg) 
M = Molecular weight of glucose(= 180) 
VI. DETERI'1INATION OF MUSCLE PHOSPHORYLASE 
(HERS, 1964) 
Principle: 
GLUCOSE-1-PHOSPHATE + GLYCOGEN 
PHOSPHORYLASE 
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Phosphorylase was measured by the liberation 
of inorganic phosphate from glucose-1-phosphate 
in the presence of glycogen. This reaction is 
the reverse of the process operating in vivo 
(HERS, 1964). Phosphorylase exists in two forms, 
namely phosphorylase a, also known as the active 
form and phosphorylase b, the inactive form. 
Phosphorylase ~ has 60-70% of its maximum activi-
ty in the absence of AMP, and phosphorylase b has 
an absolute requirement for AMP (CORI, CORI and 
GREEN, 1943). To determine the total phosphory-
lase activity, i.e. phosphorylase a and b, the 
assay was carried out in the presence of AMP. 
To measure the amount of phosphorylase b present, 
the assay was performed in the absence of AMP. 
Reagents 
'1. The substrate mixture consist"s of 
glucose-'1-phosphate, 0,'1M, glycogen, 2%, 
ar.d 
sodium fluoride, 0,2M with~ without AI'1P, 
0,003M. 
'1N HCl. 
The pH was adjusted to 6,'1 with 
2. The Fiske-Subbarow reagent consists of 
'1-amino-2-naphthol-4-sulfonic acid, O, 5 g_, 
sodium bisulfite, 30 g (anhydrous) and sodium 
sulfite, '1 g (anhydrous). The sodium bisul-
fite was dissolved in 200 ml of water. The 
other chemicaJswere added and stirred well to 
dissolve them. The reagent was filtered and 
stored in the dark. 
'10 days. 
It will keep for about 
Preparation of Tissue Extract 
The muscle samples were frozen within 5 
to 8 seconds after removal by immersing it 
immediately into liquid nitrogen. The frozen 
tissue was homogenized in the cold (4°C) in 
cold doubly-distilled water with an Ultra 
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Turrax homogenizer. The homogenate was 
diluted to a concentration of 1% (w/v) 
in cold doubly-distilled water and centri-
fuged at 1 000 x g for 10 minutes in a 
refrigerated Sorvall RC-2B centrifuge. 
Assay Procedure 
Substrate containing .Af1P (0,05 ml) and· 
substrate containing no Af1P (0,05 ml) were 
pipetted into separate test tubes. 0,05 ml 
of a 1% tissue extract was added. A blank 
containing 0,05 ml of water,and a standard 
containing 0,5 JWilOles of phosphate, instead 
of the tissue extract, was included. The 
preparations were incubated at 37°c in a water 
bath for O, 5, 10 and 20 minutes. ·The reac-
tion was terminated by the addition of 0,5 ml 
of 1N TCA. Then, in turn, were added 0,25 ml 
5% ammonium molybdate, 0,25 mi 10N H2 so4 and 
3,7 ml distilled water. The final volume was 
then 4,8 ml. After mixing well, 0,2 ml Fiske-
Subbarow reagent was added and the solution 
left at room temperature for 10 minutes to 
-92-
allow development of molybdate blue. O.D. 








X 6E = µmoles of phosphate 
liberated per ml. 
X 6E X 100 = µmoles of phosphate 
liberated per g. 




S = value of the standard 
ES= reading of the standard 
20 = dilution factor 
Phosphorylase activity was expressed in terms 





Pigs 22B and 139 developed sustained rigor. 
Pig 137 was anomalous in that it did not develop 
rigor, but pyrexia was typical. Although Pig 
137 presented no.evidence of rigor after succi-
nyl choline administration, glycolysis was never-
theless accelerated. Succinyl choline in this 
animal produced the usual type of response, i.e. 
a generalized muscular contraction, due to membrane 
depolarization, which lasted for 2 to 3 seconds 
in this animal. Immediately afterwards, skele-
tal muscle in this pig relaxed in contrast to 
animals 22B and 139 in which rigor was persistent. 
(Figs. 9 and 10). 
All three pigs developed systemic lactaci-
dosis. In Pig 137, however, its degree was 
less severe than in the other two animals. 
Blood lactate concentration of Pig 137 was 
about 5 to 6 times less than the other animals. 
Serial alterations in blood lactate concentra-
tions are shown in Figs. 11 a, band c. 
Accumulation of muscle lactate in Pig 83C is 
correlated with a fall in muscle glycogen (Fig. 12). 
The fact that the curves show the expected 2:1 
stoichiometry between lactate and glycogen 
glucose equivalents is fortuitous since lactate 
is being continuously removed by blood circulation. 
-94-
FIG. 9. 
HIND LIMBs·oF HALOTHANE SUSCEPTIBLE PIG DURING CO NTROL 
THIOPENTONE ANAESTHESIA . THE LIMBS ARE FLACCID. 
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FIG. 10. 
SAME PIG AS IN FIG. 9. 10 MIN. AFTER HALO THANE. 
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FIG. lla. PIG 22B. BLOOD LACTATE. HALO THANE ADMINISTERED 
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MIN. 
FIG. llc. PIG 137. BLOOD LACTATE. HALOTHANE ADMINISTERED AT 



































0 10 20 
MIN. 
FIG. 12. PIG 83C. MUSCLE GLYCOGEN AND LACTATE CONTENT 
DURING INDUCTION OF HYPERTHERMIA WITH HALOHANE 
(3% V/V) ADMINISTERED FROM O MIN. 









































FIG. 13. PIG 83C. BLOOD GLUCOSE DURING INDUCTION OF 
MALIGNANT HYPERTHERMIA BY HALOTHANE. HALO THANE 
{3% V/V) ADMINISTERED FROM 0-60 MIN. 
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As seen in Fig. '12 there was a fall in glyco-
gen when the concentrations of lactate in 
muscle rose. Blood glucose became elevated 
(Fig. '13). 
Determination of the glycolytic inter-
mediates was done in duplicate on each sample, 
and the average of the two readings was taken. 
Discrepant results were repeated, also in dupli-
cate. Tables II, III and IV represent the data 
on the glycolytic intermediates and cofactors 
determined in Pigs 22B, '139 and '137. In all 
the animals, following administration of succi-
nyl choline, there was a rise in muscle lactate 
which moved in parallel with the rise in blood 
lactate, with little or no alteration after 
halothane. The behaviour of individual com-
pounds is also shown in Figs. '14 a to h for Pig 
22B; '15 a to h for Pig '139 and '16 a to h for 
Pig 137. In order to localize possible points 
of glycolytic control in the system, the ratios 
of glycolytic intermediate pairs have been cal-
culated (Tables V, VI and VII and Figs. '17 a to 
f) and compared with equilibrium constants deter-
mined by WILLI.AJVISON, '1965. 
To establish whether the method used for 
estimating activation of phosphorylase ~ to a 
was satisfactory an experiment was performed on 
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rat skeletal muscle. Portions of muscle were 
taken before and after the administration of a 
lethal intravenous dose of adrenaline and the 
p~osphorylase assays were performed on each 
sample. Adrenaline should increase the percen-
tage of phosphorylase in the a form, since it 
stimulates the conversion of phosphorylase b to 
a. In this experiment, phosphorylase -5 increased 
from '12 to 48% (Fig. '18). 
Fig. '19 shows the alteration in total 
phosphorylase activity during a tYJ)ical malig-
nant hYJ)erthermic episode in Pig R'10'1 which 
in this instance was induced by halothane alone. 
&ob.,/ 
There is fluctuation in theAactivity with a 
peak immediately after introducing halothane. 
A similar pattern has been noted in one other 
pig as well as in a normal control. The exact 
significance of total phosphorylase activity is, 
however, not established since levels noted by 
others show wide fluctuations and most authors 
express phosphorylase _§. as a percentage of phos-
phorylase b instead of as absolute activity. 
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TABLE II 
GLYCOL YTIC INTERMEDIATES AND COFACTORS IN SKELETAL MUSCLE (PIG 22B) 
(AJMOLES/G. WET WT.) 
MIN -10 +1 +7 +10 +13 +14 +19 +24 
GLUC O SE-1-P HO SP HA TE 0,084 0,084 0,084 0,074 0, 168 0,213 0,232 0,274 
G LUCO SE-6-P HO SP HA TE + 0,784 0,983 0,835 0,643 1,50 1, 99 1, 75 2,14 FRUCTOSE-6-PHOSPHATE 
FRUCTOSE-1,6-DIPHOSPHATE 0,713 0,633 0,534 0,641 0,891 0,846 1,06 1,54 
DIHYDROXYACETONE PHOSPHATE 0,058 0,057 0,045 0,051 0,080 0,075 0,099 0,120 
o( -GLYCEROL PHOSPHATE 0,463 0,510 0,565 0,458 0,697 0,830 0,622 0,690 
GL YCERALDEHYDE-3-PHOSPHATE 0,003 0,004 0,004 0,003 0,005 0,004 0,008 0,014 
3-PHOSPHOGLYCERATE 0,174 0,189 0,202 0, 180 0,270 0,262 0,182 0,240 
2-PHOSPHOGLYCERATE 0,052 0,053 0,066 0,063 0,073 0,076 0,098 0,103 
PHOSPHOENOLPYRUVATE 0,073 0,074 0,073 0,068 0,087 0,084 0,066 0,090 
PYRUVATE 0,125 0,120 0, 115 0, 107 0,157 0, 197 0, 185 0, 140 
LACTATE 9,17 8,63 7,21 7,45 10,64 13,61 14,87 13, 74 
MALATE 0,058 0,068 0,066 0,073 0,045 0,085 0,066 0, 113 
ADENOSINE-5'-MONOPHOSPHATE 0, 115 0,157 0,208 0, 160 0,207 0, 197 0,098 0, 191 
ADENOSINE-5'-DIPHOSPHATE 0,565 0,701 0,816 0, 711 0,947 0,704 0,864 1,09 
ADE NO SI NE-5 '-TRIP HO SP HA TE 5,15 4,86 5,61 5,25 5,26 5,05 5,22 5,79 
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1,30 1, 90 






0, 134 0, 120 
15,58 13,48 
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MIN. 
FIG. 14a. PIG 228. MUSCLE G-1-P ((i-----®) 
G-6-P + F-6-P ( ·~) AND FDP ( iij &1 ). 
HALOTHANE ADMlt'-JISTERED AT O MIN. AND 
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FIG. 14b. PIG 228. MUSCLE DAP (~) AND GAP (.---..). 
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-10 0 +10 +20 +30 +40 
MIN. 
FIG. 14c. PIG 22B. MUSCLE oC-GP (& ~) AND MALATE (@~--,@). 
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MIN. 
FIG. 14d. PIG 22 B. 
MUSCLE 3-PG (~) A~~D 2··PG (@----@). 
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MIN. 
FIG. 14e. PIG 22 B. MUSCLE PEP (A 21\) AND PYRUVATE ((}---@). 
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FIG. 14f. PIG 22B. MUSCLE LACTATE. EXPERIMENTAL DETAILS AS 
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MIN. 
·FIG. 14g. PIG22B. MUSCLEAMP (~) AND ADP(~). 
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FfG.14h. PIG22B. MUSCLEATP (~) AND CP (~). 
EXPERIMENTAL DETAILS AS IN FIG. 14a. 
TABLE Ill 
GLYCOL YTIC INTERMEDIATES AND COFACTORS IN SKELETAL MUSCLE (PIG 139) 
(AJMOLES/G. WET WT.) 
MIN -10 -5 +4 +12! +17! +25 +35 
GLUCOSE-1-PHOSPHATE 0,074 0,098 0,220 0,199 0,486 0,421 ·O, 179 
GLUCOSE-6-PHOSPHA TE 0,584 0,752 1,56 l, 71 3,55 3,75 2,00 
FRUCTOSE-6-PHOSPHATE 0,081 0,098 0,087 0, 151 0,426 0,414 0, 194 
FRUC.TOSE-1,6-DIPHOSPHATE 0,221 0,357 0,546 0,525 1,43 1,25 l, 14 
o(-GL YCEROL PHOSPHATE 
• 
0,235 0,304 0,571 0,690 1,08 1, 12 0,624 
3-PHOSPHOGLYCERATE 0, 129 o, 151 0,289 0,264 0,212 0,214 0, 172 
2-PHOSPHOGL YCERATE 0,015 0,016 0,042 0,037 0,042 0,034 0,021 
PHO SP HOE NO LPYRUVA TE 0,092 0,071 0,040 0,042 0,037 0,031 0,043 
PYRUVATE 0,095 0,089 0, 172 0,137 0,267 0,220 0,089 
LACTATE 6,30 7,09 9,90 10,2 15,4 15,5 10,6 
MALATE 0,055 0,069 0, 130 0,228 0,212 0,241 0,271 
ADENOSINE-5'-MONOPHOSPHATE 0,125 0, 126 0, 142 0,219 0, 156 0,159 0, 132 
ADENOSINE-5'-DIPHOSPHATE .0,489 0,528 0,648 0,783 0,708 0,682 0,418 
ADENOSINE-5'-TRIPHOSPHATE 4,37 4,32 4,86 5,07 5,30 5,53 2,82 
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MIN. 
FIG. 15a. PIG 139. MUSCLE G-1-P (@----0) AND G-6-P (&---A). 
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FIG. 15b. PIG 139. MUSCLE F-6-P (®-----9) AND FDP (A.=--Ai). 
EXPERIMENTAL DETAILS AS IN FIG. 15a. 
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MIN. 
FIG. 15c. PIG 139. MUSCLE oC-GP (.&--&) AND MALATE (@--@). 
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FIG. 15d. PIG 139. MUSCLE 3-PG (~) AND 2-PG (@--@ ). 
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MIN. 
FIG. 15e. PIG 139. MUSCLE PEP (.&r---A) AND PYRUVATE (@----@). 
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MIN. 
FIG. 15 f. PIG 139. MUSCLE LACTATE. EXPERIMENTAL DETAILS AS 
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MIN. 
FIG. 15g. PIG 139. MUSCLE AMP(~) AND ADP (o----@). 

















-10 0 +10 +20 +30 +40 
MIN. 
FIG. 15h. , PIG 139. MUSCLE ATP (~) AND CP (A A). 
EXPERIWJ:NTAL DETAILS AS IN FIG. 15a. 
TABLE IV 
GLYCOL YTIC INTERMEDIATES AND COFACTORS IN SKELETAL MUSCLE (PIG 137) 
(AJMOLES/G. WET WT.) 
MIN -5 +2 +5 +15 +20 +25 
GLUCOSE-1-PHOSPHATE 0,047 0,037 0,024 0,084 0,068 0,404 
GLUCOSE-6-PHOSPHA TE 0,956 0,656 0,529 0,831 0,627 7,98 
FRUC TO SE-6-P HO SP HA TE 0, 102 0,094 0,073 0,071 0,068 0,933 
FRUCTOSE-1,6-DIPHOSPHATE 0,450 0,887 1, 14 1,42 1,28 1,87 
o<-GLYCEROL PHOSPHATE 0,411 0,571 0,605 0,650 0,903 1,27 
3-PHOSPHOGLYCERATE 0, 134 0,155 0, 181 0,191 0,173 0, 121 
2-PHOSPHOGLYCERATE 0,047 0,058 0,055 0,045 0,050 0,050 
PHOSPHOENOLPYRUVATE 0,063 0,079 0,079 0,076 0,087 0,084 
PYRUVATE 0,228 0,168 0,168 0, 124 0,121 0,393 
LACTATE 11,9 10,2 13,3 13,5 15,9 25,6 
MALATE 0, 131 0,126 0,136 0,131 0,155 0,280 
ADE NO SI NE-5'-MO NO PHOSPHATE 0,228 0,241 0,265 0,236 0,283 0,283 
ADE NOSI NE-5 '-DIP HO SP HATE 0,604 0,668 0,747 0,755 0,750 0,923 
ADE NOS I NE-5 '-TRIP HO SP HA TE 5,41 7,38 7,35 6,90 6,37 5,89 
CREA Tl NE PHO SP HA TE 5,83 4,99 5,30 6,68 4,73 3,18 
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FIG. 16a. PIG 137. MUSCLE G-1-P (~) AND G-6-P (A A). 
HALOTHANE ADMINISTERED AT O MIN. AND SUCCINYL CHOLINE 
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FIG. 16b. PIG 137. MUSCLE F-6-P (~) AND FDP (.&-. ---A). 
EXPERIMENTAL DETAILS AS IN FIG. 16a. · 
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FIG. 16c. PIG 137. MUSCLE oC-GP ( A £.) AND MALATE (~). 
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MIN. 
FIG. 16d. PIG 137. MUSCLE 3-PG ( A 6) AND 2-PG (~ ). 
EXPERIMENTAL DETAILS AS IN FIG. 16a. 
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FIG. 16e. PIG 137. MUSCLE PEP (.&;-. ---&) AND PYRUVATE (o---@). 
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MIN, 
FIG. 16g. PIG 137. MUSCLE AMP (A-~) AND ADP (9 8). 
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MIN. 
FIG. 16h. PIG 137. MUSCLE ATP (@ @) AND CP (&--A). 
EXPERIMENTAL DETAILS AS IN FIG. 16a. 
TABLE V 
MASS/ACTION RELATIONSHIP OF GLYCOLYTIC REACTIONS (PIG 22B) 
MIN -10 +1 +7 +10 +13 +14 +19 +24 +30 +38 
~-PQ) 3,35 
~-P~ 
3,57 3,06 2,86 3,70 3,45 1,86 2,33 3,44 2,60 
[-P~ 0,96 1,23 0,712 0,72 0,91 0,93 0,84 0, 91 1,48 1, 14 
rE~~21 
~E~IAD~ i 0,096 0,091 0,080 0,051 0,069 0,073 0,068 0,079 0,047 0,047 
~~~TP] 5 




1,6 X 10 
-1 




MASS/ACTION RELATIONSHIP OF GLYCOLYTIC REACTIONS (PIG 139) 
-10 -5 +4 +12! +17! . +25 +35 +45 
Equilibrium 
MIN constants * 
IG-1-~ 
-2 
0, 126 0, 130 0, 141 0,116 0, 136 0, 112 0,089 0,095 5,
8 X 10 
@-6-~ 
@-6-~ 7,21 7,67 17,9 11,3 8,33 9,06 10,3 7,66 3,8
5 
l}-6-P] 
[f-6-~ ~T~ i 0,95 -
4 
2,61 1,80 0,96 1,49 1, 78 2,15 0,92 8
,3 X 10 
(£DP] ~DP] 5 




0, 163 0,225 1,05 0,88 1, 14 1, 10 0,488 1,6 
X 10 
~E~ ~ 2oJ 
[pEP] IADB ± 0,078 -4 0,085 0,077 0,023 0,036 0,014 0,013 0,054 8,7 X 10 
~YR] ~TP]5 
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FIG. 170. PIG 139. THE MASS/ACTION RELATIONSHIP OF THE 
PHOSPHOGLUCOMUTASE REACTION CALCULATED FROM 
SKELETAL MUSCLE CONTENT OF G-1-P AND G-6-P. 
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MIN. 
FIG. 17b. PIG 139. THE fv'\.ASS/ACTION RELATIONSHIP OF THE 
PHOSPHOGLUCOSE ISOMERASE REACTION CALCULATED 
FROM SKELETAL MUSCLE CONTENT OF G-6-P AND F-6-P. 








-10 0 +10 +20 +30 
MIN. 
FIG. 17c. PIG 139. THE i\t\ASS/ACTION RELATIONSHIP OF THE 
PHOSPHOFRUCTOKINASE REACTION CALCULATED FROM 
SKELETAL MUSCLE CONTENT OF F-6-P AND FOP. 









-10 0 +10 +20 +30 
MIN. 
FIG. 17d. PIG 139. THE MASS/ACTION RELATIONSHIP OF THE 
PHOSPHOGL YCERA TE MUTASE REACTION CALCULATED 
FROM SKELETAL MUSCLE CONTENT OF 3-PG AND 2-PG. 
EXPERIMENTAL DETAILS AS IN FIG. 15a. 
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-10 0 +10 +20 +30 
MIN. 
FIG. 17e. PIG 139. THE MASS/ACTION RElATIONSHIP OF THE ENOLASE 
REACTION CALCUlATED FROM SKELETAL MUSCLE CONTENT OF 













+10 +20 +30 +40 
MIN. 
FIG. 17f. PIG 139. THE MASS ACTION RELATIONSHIP OF THE PYRUVATE KIN\SE 
REACTION CALCULATED FROM SKELETAL MUSCLE CONTENT OF PEP AND 
PYRUVATE. EXPERIMENTAL DETAILS AS IN FIG. 15a. 
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TABLE VII 
MASS/ACTION RELATIO~SHIP OF GLYCOLYTIC REACTIONS (PIG 137) 




0,049 0,056 0,045 0, 101 0, 108 0,050 
-2 
[G-6-~ 
5,8 X 10 
@-6-~ 
9,38 6,98 7,25 11,7 9,22 8,55 3,85 
~-6-~ 
[f_-6-~ ~ T~ 4 
1,63 0,936 0,505 0,366 0,361 2,54 
-4 
~D~ ~D~ 
8,3 X 10 
5 
@-P~ 
2,85 2,67 3,29 4,24 3,46 2,42 6,5 
~-P~ 
~-Pg 




[re~ [Aoe] _1. 0,024 0,033 0,038 0,053 0,067 0,026 -4 
~~~T~ 5 
8, 7 X 10 
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FIG. 18. THE EFFECT OF ADRENALINE ON PHOSPHORYLASE ACTIVITY 
OF RAT SKELETAL MUSCLE. CONTROL -AMP (& A) 
CONTROL +AMP (@---0) POST ADRE NALi NE -AMP (6- -l-:,) 






















-20 -JO 0 +JO +20 +30 
MIN. 
FIG. 19. PIG RlOl. TOTAL SKELETAL MUSCLE PHOSPHCRYLASE 
ACTIVITY (DETERMINED IN THE PRESENCE OF AMP) 






0 6 12 18 24 30 
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FIG. 20. PIG Rl01. PHOSPHORYLASE ACTIVITY MEASURED WITH AND 
WITHOUT AAAf', AT -20 MIN. DURING THIOPEt·HONE ANAESTHESIA. 
THE PHOSPHOMOLYBDA TE COLOUR PRODUCED BY RELEASED P. FROM 
G-1-P (SEE DETAILS IN METHODOLOGY) IS PLOfTED ON AB5t:ISSA 
AGAINST INCUBATION TIME. 
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All determinations of pig muscle phos-
phorylases ~ and b both in control and hyper-
thermic animals failed to reveal any phospho-
rylase activity in the absence of A1'1P (Fig. 20). 
In fact, there was a slight drop instead of an 
increase in Pi as measured by the phosphomolyb-
date method indicating an absence of phosphorylase 
a activity. Phosphorylase activities were de-
termined in three pigs; one normal and two 
hyperthermic pigs. Serial determinations 
before and after the administration of halothane, 
amounting to a total of 20 determinations for 
the three pigs, all showed no Pi release from 
G-1-P in the absence of Al"IP under the conditions 
·of the assay. 
COJVI1'1ENT ON RESULTS 
Concentrations of all glycolytic inter-
mediates in skeletal muscle rose significantly 
during succinyl choline-induced acceleration of 
glycolytic flux. The compounds most affected 
were glucose-1-phosphate, glucose-6-phosphate, 
fructose-6-phosphate, fructose-1,6-diphosphate 
and oC-glycerophosphate, all these being 
elevated 3 and '10 fold, as compared with 
control values. 3-Phosphoglycerate and 
2-phosphoglycerate were less affected. 
In Pig 22B and Pig '139, concentrations of 
2- and 3-phosphoglycerates rose to app.roxi-
mately twice the starting concentrations. 
In Pig 137 the concentrations remained 
unchanged. 
Malate, AJ:'1P and ADP concentrations in-
creased slightly about 2 to 3 fold of the 
value at the outset. In Pig '137, the AMP 
content did not change. 
Concentrations of phosphoenolpyruvate 
and pyruvate were unaltered, except for Pig 
'139, in which the concentration of phospho-
enolpyruvate fell and Pig '137, whose pyruvate 
concentration rose about 2 fold. 
Creatine phosphate in the muscle of Pig 
'139 fell rapidly from '10 to 2 µmoles/g. wet 
wt. whilst that of Pig 22B declined only from 
'1'1 to 9 µ.moles/g. wet wt. In Pig '137, the 
initial concentration of CP was less and sub-
sequently fell from 5 to 3 µmoles/g. wet wt. 
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Concentrations of muscle ATP in Pig 137 
and Pig 22B were maintained after glycolytic 
flux had been vastly accelerated. In Pig 
139, however, there was a slight fall in ATP 
concentration, from 4 to 3 prnoles/g. wet wt. 
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PART IV 
D I S C U S S I O N 
The disappearance of glycogen from 
skeletal muscle, the elevation of muscle and 
plasma lactate, and the rise in blood glucose 
were observed following the induction of the 
syndrome, Malignant Hyperthermia, in these 
pigs. These biochemical changes in the in-
tact animal, which are part of the syndrome, 
are the consequences of rapid breakdown of 
muscle glycogen. This fact does not, however, 
exclude the possibility that reversal of glyco-
lysis in muscle is somewhat impaired or that 
the rate of hepatic uptake of lactic acid from 
the blood is restricted. Such phenomena could 
contribute. in part to the elevated concentrations 
of lactic acid which were observed. Neverthe-
less, in view of the rapid rate of accumulation 
of plasma lactate, it is felt that stimulation 
of glycogen breakdown was the mechanism of para-
mount importance. 
In terms of stoichiometry, muscle glycogen 
can account for the elevated levels of plasma 
lactate (20 - 25 mM) attained in this condition. 
It has also been computed that approximately 50% 
of the excess heat appearing during Malignant 
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Hyperthermia can be accounted for in terms 
of this rapid glycolytic flux (BER.MAJ.~ and 
KENCH, 1971). 
It would seem obvious to consider if 
muscle rigor or contraction encountered in 
this condition also arises from accelerated 
glycogen breakdown. The exact mechanism by 
which glycogen catabolism is initiated during 
normal muscular contraction is still in dis-
pute (pp. 31-33). It would seem, however, that 
Ca++ i·ons could "d th 1· kb t provi e e in e ween muscu-
lar contraction and glycogenolysis. A 
reversible system for the activation of the 
phosphorylase step by ca++ has recently been 
demonstrated (OZAWA, HOSOI and EBASHI, 1967; 
HEill1EYER, MEYER, HASCHKE and FISCHER., 1970). 
Malignant Hyperthermia in human patients 
can be divided into two groups on the basis of 
the presence or absence of muscle rigor. Two 
separate mechanisms may, therefore, be capable 
of starting this syndrome. Irrespective of 
the primary stimulus, hyperpyrexia and lactaci~ 
dosis develop, although the nature of the latter 
has not been fully elucidated (KALOW, BRITT, 
TERR.EAU and HAIST, 1970). All previous animals 
studied in this laboratory up till the present, 
approximately 30, have developed rigor and 
hyperthermia. Pig 137 described here is the 
first animal suffering from hyperthermia with-
out rigor which has been described to our know-
ledge, and he was similar, therefore, to the 
non-rigorous human patients. 
It has been previously.shown that rigor is 
not associated with low concentrations of ATP 
in the muscle (BER1'1AN, HARRISON, BULL and KENCH, 
1970). Rigor developed in Pigs 22B and 139 
whilst ATP levels remained above 4 - 5 µmoles/g. 
wet weight and in Pig 139 ATP did not fall until 
just prior to death. In Pig 22B, ATP remained 
constant. Onset of rigor does not appear to 
be caused by depletion of ATP. HARRISON, 
SAUNDERS, BIEBUYCK, HICKMAN, DENT, WEAVER and 
TERBLANCHE (1969) demonstrated that in vitro 
the muscle of pigs prone to hyperthermia, as 
compared with normal pigs, had a tendency to-
wards an abnormal fall in ATP content. This 
drop was only apparent after prolonged incuba-
tion. 
-148-
Concentrations of creatine phosphate in 
the muscle were initially maintained in the 
hyperthermic syndrome, although resting levels 
in susceptible pigs appeared to be lower than 
usually recorded in skeletal muscle (15 µmoles/ 
g.wet weight). In Pig 139, however, CP did 
fall considerably, from 10 to 2 µmoles/g.wet 
weight. 
The trend of creatine phosphate concentra-
tion was a downward course as hyperthermia con-
tinued, but ATP concentration was not lowered. 
This was presu.rnably due to resynthesis of ATP 
by an&@r-obio glyeoiy@i§, ~t th@ ®XlJ@fi@® of ADF. 
If this is true, ADP may not be the crucial 
stimulator of glycogenolysis. ADP levels did 
not, in fact, rise significantly as would be 
expected if the nucleotide was responsible for 
activation of phosphofructokinase • 
.Al'1P followed the same trend as ADP, an~ 
stayed constant in Pig 137, and rose only 
slightly in Pigs 22B and 139. A1'1P, like ADP, 
could not, therefore, be envisaged as an acti-
vator of the phosphofructokinase step, nor be 
responsible for acceleration of the phosphorylase 
step, nor be responsible for acceleration of the 
phosphorylase step by functioning as an activator 
-149-
of phosphorylase b: unless, that is, AMP is 
present in small discrete pools in high concen-
tration in the locality of these enzymes, the 
contribution of such minute metabolic backwaters 
being too small to be appreciated in measurements 
of overall cellular AMP. 
Individual glycolytic intermediates were 
assayed and the ratios of intermediate pairs 
were calculated in order to locate the control 
points in this system. The glycolytic flux 
was accompanied by elevation of most of the 
glycolytic intermediates. 
increase in the ratio @-P~ 
[PEP] 
139, pointing to the enolase 
There was a slight 
in Pigs 22B and 
step as slightly 
rate-limiting. In Pigs 22B and 137, there 
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was an increase in the ratio ~EP] ~DP] suggesting 
(?YR] ~Tfj 
that the pyruvate kinase step might be facili-
tated. This ratio for Pig 139 dropped. slightly. 
The ratios did not approach the values seen dur-
ing stimulation of anaerobic glycolysis in per-
fused rat heart in which the ratio of the concen-
trations of these substrates was dramatically 
altered and in such a way as could arise from 
activation of PFK (WILLIAMSON, 1966). The 
inference is that no particular control point 
was stimulated or became rate limiting on the 
augmented flow of skeletal muscle glycogenoly-
sis in porcine Malignant Hyperthermia. 
These observations raise the question 
whether a simple mechanism, based on the acti-
vation of glycogen phosphorylase, could be 
responsible for the increased glycolytic flux. 
No conversion of phosphorylase b to.§:. could be 
demonstrated during the increased catabolism 
of glycogen. There was also no significant 
accumulation of .A1'1P which could account for 
the in vivo activity of the .A1'1P-dependent phos-
phorylase b form. This mechanism of phosphory-
lase activation is, in any event, of doubtful 
physiological significance. The rapid glyco-
genolysis and lactate accumulation which occurs 
post-mortem in some pigs has been proven to be 
associated with the development of a pale, soft 
exudative (PSE) condition in the skeletal muscle. 
A pattern of changes in glycolytic intermediates, 
similar to that obtaining in hyperthermia, has 
been demonstrated in muscle of animals which, 
after death, exhibit P.S.E. 




to a conversion was also not demonstrable in 
conditions prevailing in P.S.E. (BER1'1AN and 
KENCH, UNPUBLISHED OBSERVATIONS). 
The techniques employed to demonstrate 
possible b to~ conversion appear to be valid, 
since, in the present study, it was shown that 
adrenaline stimulation in vivo induced 48% and 
66% conversion of phosphorylase b to a in rat 
and pig skeletal muscle respectively. It is 
conceivable that change of phosphorylase b to 
a occurred in vivo, but that inactive phospho-
rylase b was regenerated by phosphorylase phos-
phatase, an enzyme in skeletal muscle known to 
be particularly active during isolation proce-
dures. 
Activation of a muscle glycogen particle 
by ca++ has been studied by HEill1EYER, 1'1EYER, 
HASCHKE and FISCHER, 1970. They observed that 
the addition of Mg-ATP and Ca++ caused an imme-
diate activation of phosphorylase b to a, referred 
to as the "flash activation" of phosphorylase. 
It is this.rapidly reversible ionic activation 
by Ca++ which makes it such a particularly suit-
able mechanism for rapid control of metabolic 
requirements of muscle cells. There is evidence 
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that ca++ is liberated from intracellular 
binding sites in skeletal muscle during onset 
of Malignant Hyperthermia. BERMAN, HARRISON, 
BULL and KENCH ('1970) have demonstrated a 
rapid rise in plasma ca++ during development 
of Malignant Hyperthermia. 
Ca++ accumulation by ·sarcoplasmic reticu-
lum of rigid and of non-rigid patients who 
recovered after an episode of Malignant Hyper-
thermia has been investigated by KALOW, BRITT, 
TERREAU and HAIST ('1970). ++ Ca uptake by the 
sarcoplasmic reticulum of the non-rigid patient 
was normal, but that of the rigid patients was 
diminished. There appears to be some defect 
in the sarcoplasmic ~eticulum activity of these 
patients. HARRISON ('1970) has shown that the 
syndrome of Malignant Hyperpyrexia in susceptible 
Landrace pigs can be prevented by treatment with 
procaine, which is known to prevent caffeine-
induced rigor which accrues from inhibition of 
rebinding of ca++ to the sarcoplasmic reticulum. 
Release of ca++ would serve to activate a myosin-
ATP-ase and the contractile mechanism and also to 
provoke rigor. 
The above arguments are based upon absence 
of changes in concentration of factors known to 
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control glycolytic flux. The concentrations 
of ATP and other cofactors determined in this 
study were those of the whole tissue, and one 
cannot exclude, at this time,that local accu-
mulation of ADP within the relevant cellular 
compartments could have accelerated glycogeno-
lysis. 
From the present study, a sequence of 
events during development of the syndrome 
Malignant Hyperpyrexia has emerged. The disease 
is based on a genetic susceptibility to the 
effects of succinyl choline or halothane. 
These anaesthetic agents appear to interfere 
with the binding capacity of ca++ by the sarco-
plasmic reticulum. The defective sarcoplasmic 
' 
reticulum releases ca++ into the sarcoplasm, 
where, in turn, it stimulates glycogen phospho-
rylase, activates the contractile mechanism 
resulting in rigor or contracture of skeletal 
' ++ muscle and stimulates Ca -activated Myosin-ATP-
ase. The rapid bre~k.doc.:< .. m 1. of ATP is offset 
by resynthesis from phosphate and from increased 
glycolytic rate. 'When these sources of supply 




Skeletal muscle metabolism in the syndrome, 
Malignant Hyperpyrexia, induced by the anaesthe-
tic agents halothane or succinyl choline has 
been studied. The most outstanding biochemical 
feature of this syndrome is the development of 
severe systemic lactacidosis, due to the acQele-
rated breakdown of skeletal muscle glycogen. 
This accompanies the development of hyperthermia, 
and rigidity or rigor of the limbs. 
In order to establish the origin of the 
lactacidosis and mechanism of activation of 
glycogenolysis, the glycolytic intermediates of 
skeletal muscle have be-en measuredo There is 
a rise in all the glycolytic intermediates; some 
more than others. The most affected were glucose 
-'1-phosphate, glucose-6-phosphate, fructose-6-
phosphate, fructose-'1,6-diphosphate and o<:.-glycero-
phosphate. ATP levels remained constant and only 
dropped prior to death. The ATP levels are thus 
maintained by the increased glycolytic flux. 
Creatine phosphate levels were variable but fell 
if pre-rigor levels were not depressed. Muscle 
al-glycerophosphate, malat.e and lactate content 
were all increased suggesting that NADH is accumu-
lating in the cytosol. 
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The mass/action ratios of the glycolytic 
intermediates have been calculated in order to 
locate the control points in this system. 
The ratios [2PG]/(}'Ep_] and !YEP_] [AD~ / [J:iYaj [AT~ 
were increased suggesting that the enolase step 
was slightly rate limiting and the pyruvate ki-
nase step was activated; the latter possibly 
by increased availability of ADP although total 
muscle ADP concentration did not increase signi-
ficantly. The phosphofructokinase step did not 
appear to be specifically activated. 
It is postulated that accelerated glycogeno-
lysis is due to activation of the phosphorylase 
reaction and that intermediates accumulate due 
to subsequent rate limiting steps. 
No phosphorylase b to a conversion could 
be detected during increased glycogenolysis but 
it is suggested that this activation does occur 
by a "flash activation" induced by liberation of 
Ca++ from intracellular binding sites possibly 
consequent to a defect in uptake of Ca++ by the 
sarcoplasmic reticulum which follows halothane 
or succinyl choline in the susceptible animal. 
Release of ca++ can thus account for enhanced 
-156-
myofibrillar ATPase activity, rigor and 
acceleration of muscle glycogenolysis by 
activation of phosphorylase similar to the 
coordination of these processes which occur 
during physiological muscle activity. 
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